Processing 00000000.tx.1: The 51 Integrin Mediates Elimination of Amyloid- Peptide and Protects Against Apoptosis Michelle L. 

Phrase: "The 51 Integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "Mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "Elimination of Amyloid- Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "Protects Against Apoptosis Michelle L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.2: Matter,* Zhuohua Zhang,* Christer Nordstedt, and Erkki Ruoslahti* *La Jolla Cancer Research Center, The Burnham Institute, La Jolla, California 92037; 

Phrase: "Matter,"

Phrase: "* Zhuohua Zhang,"

Phrase: "* Christer Nordstedt,"

Phrase: "and"

Phrase: "Erkki Ruoslahti"

Phrase: "*"

Phrase: "*La Jolla Cancer Research Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1513817:Cancer Center [Health Care Related Organization]
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "The Burnham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "California 92037"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: ";"
Processing 00000000.tx.3: Department of Neurobiology, Harvard Medical School, and Division of Neuroscience, The Children's Hospital, Boston, Massachusetts 02115; 

Phrase: "Department of Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Division of Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "The Children's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020017:Children's hospital [Health Care Related Organization]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02115"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: ";"
Processing 00000000.tx.4: and Department of Clinical Neuroscience, The Karolinska Hospital, Stockholm, Sweden S-171 76  Abstract Top Abstract Introduction Materials & Methods Results Discussion References The amyloid- peptide (A) can mediate cell attachment by binding to 1 integrins through an arg-his-asp sequence. 

Phrase: "and"

Phrase: "Department of Clinical Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "The Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "S-"

Phrase: "171 76  Abstract Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)"

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell attachment by binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0887869:Cell Attachment [Cell Component]
   770   C0185023:Attachment [Therapeutic or Preventive Procedure]
   770   C1947904:Attachment [Activity]
   770   C1999228:Attachment [Intellectual Product]

Phrase: "to 1 integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "through an arg-"

Phrase: "his-asp sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.5: We show here that the 51 integrin, a fibronectin receptor, is an efficient binder of A, and mediates cell attachment to nonfibrillar A. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "the 51 integrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "a fibronectin receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0081938:Fibronectin receptor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1138422:Fibronectin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "an efficient binder of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0179302:Binder [Medical Device]
   760   C1706253:Binder [Biomedical or Dental Material]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell attachment to nonfibrillar A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0887869:Cell Attachment [Cell Component]
   760   C0185023:Attachment [Therapeutic or Preventive Procedure]
   760   C1947904:Attachment [Activity]
   760   C1999228:Attachment [Intellectual Product]
Processing 00000000.tx.6: Cells engineered to express 51 internalized and degraded more added A1-40 than did 51-negative control cells. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "51"

Phrase: "internalized"

Phrase: "and"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "more added A1-40 than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205172:More [Functional Concept]
   760   C0439509:/40 [Temporal Concept]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "did"

Phrase: "51-negative control cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Deposition of an insoluble A1-40 matrix around the 51-expressing cells was reduced, and the cells showed less apoptosis than the control cells. 

Phrase: "Deposition of an insoluble A1-40 matrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposition [Functional Concept]

Phrase: "around the 51-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "less apoptosis than the control cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.8: Thus, the 51 integrin may protect against A deposition and toxicity, which is a course of Alzheimer's disease lesions.  

Phrase: "Thus,"

Phrase: "the 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "may"

Phrase: "protect against A deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a course of Alzheimer's disease lesions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0242656:disease course [Pathologic Function]
   753   C0750729:Course [Temporal Concept]
Processing 00000000.tx.9: Introduction Top Abstract Introduction Materials & Methods Results Discussion References INTEGRIN-mediated cell adhesion is necessary for the survival of many types of cells, and loss of adhesion causes apoptosis (reviewed in Frisch and Ruoslahti, 1997). 

Phrase: "Introduction Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "INTEGRIN-mediated cell adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512810:Integrin-mediated Cell Adhesion [Cell Function]
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "necessary for the survival of many types of cells,"

Phrase: "and"

Phrase: "loss of adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in Frisch"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Ruoslahti,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.10: The 51 integrin may have a particularly prominent antiapoptotic effect because 51 is the only integrin that protects cells from apoptosis in serum-free cultures (Zhang et al., 1995; 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "may"

Phrase: "have"

Phrase: "a particularly prominent antiapoptotic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "because"

Phrase: "51"

Phrase: "is"

Phrase: "the only integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "that"

Phrase: "protects"

Phrase: "cells from apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "in serum-free cultures"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0010453:Cultures [Idea or Concept]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Zhang et al.,"

Phrase: "1995"

Phrase: ";"
Processing 00000000.tx.11: O'Brien et al., 1996). 

Phrase: "O'Brien et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.12: 51-mediated adhesion upregulates the antiapoptosis protein Bcl-2 (Zhang et al., 1995), and 51 is one of a few integrins that activates the signaling protein Shc (Wary et al., 1996). 

Phrase: "51-mediated adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "upregulates"

Phrase: "the antiapoptosis protein Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(Zhang et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "51"

Phrase: "is"

Phrase: "one of a few integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the signaling protein Shc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705297:SHC [Gene or Genome]
   734   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Wary et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.13: These signaling events may partly explain its antiapoptotic effects. 

Phrase: "These signaling events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "may"

Phrase: "partly"

Phrase: "explain"

Phrase: "its antiapoptotic effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.14: 1 integrins have been shown to mediate cell adhesion to the amyloid beta (A)1 protein, and 51 has been proposed to be the integrin responsible for the A binding (Ghiso et al., 1992). 

Phrase: "1 integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell adhesion to the amyloid beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(A)1 protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "51"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "responsible for the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "(Ghiso et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.15: The amino acid sequence arg-his-asp (RHD) has been pinpointed as the integrin recognition site in A (Ghiso et al., 1992; Sabo et al., 1995). 

Phrase: "The amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "arg-"

Phrase: "his-asp (RHD)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035439:rhd [Disease or Syndrome]
   861   C1419382:RHD [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "pinpointed as the integrin recognition site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0205145:Site [Spatial Concept]
   753   C0524637:Recognition [Mental Process]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "in A (Ghiso et al.,"

Phrase: "1992"

Phrase: "; Sabo et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.16: This sequence resembles the general integrin recognition sequence RGD present in many extracellular matrix proteins (Ruoslahti, 1996a). 

Phrase: "This sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "resembles"

Phrase: "the general integrin recognition sequence RGD present in many extracellular matrix proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0150312:Present [Quantitative Concept]
   736   C0449450:Present [Idea or Concept]

Phrase: "(Ruoslahti,"

Phrase: "1996a"

Phrase: ")."
Processing 00000000.tx.17: A is a 39-42 amino acid protein derived from proteolytic cleavage of a larger membrane-spanning glycoprotein, the amyloid precursor protein (APP; Kang et al., 1987). 

Phrase: "A"

Phrase: "is"

Phrase: "a 39-42 amino acid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derived from proteolytic cleavage of a larger membrane-spanning glycoprotein,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   757   C0025248:Membrane Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0010813:cleavage [Cell Function]
   739   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   739   C0025255:Membrane [Tissue]
   739   C0443228:larger [Quantitative Concept]
   739   C0549177:Larger [Quantitative Concept]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C0596901:Membrane [Cell Component]
   739   C0597304:Proteolytic [Molecular Function]
   739   C1330957:cleavage [Cell Function]
   739   C1441547:Derived [Qualitative Concept]
   739   C1704243:Larger [Quantitative Concept]
   739   C1706182:Membrane [Manufactured Object]
   739   C1947941:proteolytic [Enzyme]
   739   C3245521:derived [Idea or Concept]
   706   C1711300:Span [Conceptual Entity]
   706   C2700613:Span [Quantitative Concept]

Phrase: "the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "; Kang et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.18: A forms fibrillar aggregates that can cause cell death by apoptosis (Loo et al., 1993; Pike et al., 1993; Lorenzo and Yanker, 1994). 

Phrase: "A forms fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death by apoptosis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   846   C0162638:apoptotic cell death [Cell Function]
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "(Loo et al.,"

Phrase: "1993"

Phrase: "; Pike et al.,"

Phrase: "1993"

Phrase: "; Lorenzo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "Yanker,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.19: Enhanced deposition of A matrix within the cortex, hippocampus, and vasculature of the brain correlates with neuronal cell death and ultimately dementia in Alzheimer's disease (AD; reviewed by Selkoe, 1994). 

Phrase: "Enhanced deposition of A matrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "within the cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vasculature of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C2338916:Vasculature of brain [Body Location or Region]
   770   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "correlates with neuronal cell death"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "ultimately dementia in Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(AD"

Phrase: ";"

Phrase: "reviewed by Selkoe,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.20: Two predominant forms of A (1-40 and 1-42) exist in AD that differ by two amino acid residues at the hydrophobic COOH terminus, a domain that is required for nucleation-dependent fibril formation (Jarret et al., 1993). 

Phrase: "Two predominant forms of A (1-40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "exist in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "differ by two amino acid residues"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205448:Two [Quantitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at the hydrophobic COOH terminus,"

Phrase: "a domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "required for nucleation-dependent fibril formation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0220781:formation [Biologic Function]
   753   C0225328:Fibril [Cell Component]
   753   C0439634:formation [Spatial Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1514873:Required [Functional Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1948066:Fibril [Physical Object]
   753   C3244310:dependent [Functional Concept]

Phrase: "(Jarret et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.21: The A1-40 form has a slower rate of fibril formation in vitro than the A1-42 form (Jarret et al., 1993). 

Phrase: "The A1-40 form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "a slower rate of fibril formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in vitro than the A1-42 form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "(Jarret et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.22: There is evidence for three mechanisms of A accumulation: overproduction of A, production of longer forms of A (which aggregate more), and impaired clearance of A. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence for three mechanisms of A accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: ":"

Phrase: "overproduction of A,"

Phrase: "production of longer forms of A ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "which"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "impaired clearance of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.23: The clearance pathways for fibrillar and soluble A are incompletely known. 

Phrase: "The clearance pathways for fibrillar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "soluble A"

Phrase: "are"

Phrase: "incompletely"

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.24: Two cell surface receptors are known to bind A. 

Phrase: "Two cell surface receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   861   C0699040:Cell surface [Cell Component]
   812   C0205148:Surface [Spatial Concept]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A."
Processing 00000000.tx.25: The scavenger receptor present on glial cells binds specifically to fibrillar A, and appears to mediate clearance of small fibrillar A aggregates in vitro (Paresce et al., 1996; Khoury et al., 1996). 

Phrase: "The scavenger receptor present on glial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to fibrillar A,"

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "clearance of small fibrillar A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Paresce et al.,"

Phrase: "1996"

Phrase: "; Khoury et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.26: The receptor for advanced glycation end products binds both the soluble and fibrillar forms of A, and may mediate some of the cytotoxic effects of fibrillar A (Yan et al., 1996). 

Phrase: "The receptor for advanced glycation end products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "both the soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "fibrillar forms of A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "some of the cytotoxic effects of fibrillar A (Yan et al.,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   754   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   738   C0205392:Some [Quantitative Concept]
   738   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   738   C1280500:effects [Qualitative Concept]
   738   C1511636:cytotoxic [Functional Concept]
   738   C3540770:Some [Intellectual Product]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.27: Because 51 may also be an A receptor, and because 51 and A have apparently contrasting effects on apoptosis, we sought to determine whether 51 is indeed an A-binding integrin and, if so, what effect it might have on the metabolism of A and on cell survival. 

Phrase: "Because"

Phrase: "51"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "an A receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "because"

Phrase: "51"

Phrase: "and"

Phrase: "A"

Phrase: "have"

Phrase: "apparently contrasting effects on apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "51"

Phrase: "is"

Phrase: "indeed"

Phrase: "an A-binding integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: ","

Phrase: "if"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "what effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "might"

Phrase: "have on the metabolism of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C3154893:Have [Idea or Concept]
   753   C3539897:Have [Qualitative Concept]

Phrase: "and on cell survival."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007620:Cell Survival [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.28: We show here that nonfibrillar A binds to the 51 integrin, and that this interaction promotes clearance of A by cultured cells, reducing the formation of an insoluble A fibrillar matrix and counteracting the toxic effects of the A matrix. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that nonfibrillar A"

Phrase: "binds to the 51 integrin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "clearance of A by cultured cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the formation of an insoluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "A fibrillar matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "counteracting"

Phrase: "the toxic effects of the"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   760   C1280500:effects [Qualitative Concept]
   760   C1407029:Toxic [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "A matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]
Processing 00000000.tx.29: These results suggest a new function for 51 as a binder of A and a regulator of brain cell survival.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a new function for 51"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "as a binder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179302:Binder [Medical Device]
  1000   C1706253:Binder [Biomedical or Dental Material]

Phrase: "of A"

Phrase: "and"

Phrase: "a regulator of brain cell survival."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.30: Materials and Methods Top Abstract Introduction Materials & Methods Results Discussion References Cells The human neuroblastoma cell line (IMR-32) was obtained from the American Type Culture Collection (Rockville, MD). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "The human neuroblastoma cell line"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0027819:Neuroblastoma [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C0700095:neuroblastoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(IMR-32"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from the American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   853   C0598079:American Type Culture Collection [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0596070:American [Population Group]
   748   C1301820:Obtained [Functional Concept]
   748   C1516698:Collection [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704814:Collection [Idea or Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1706701:Obtain [Activity]

Phrase: "(Rockville,"

Phrase: "MD)."
Processing 00000000.tx.31: The CHO-B2 cells deficient in 51 were from Dr. 

Phrase: "The CHO-B2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "deficient in 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011155:Deficient [Functional Concept]
   790   C1636779:% deficient [Quantitative Concept]

Phrase: "were from Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.32: Rudolf Juliano (School of Medicine, University of North Carolina, Chapel Hill, NC; Schreiner et al., 1989). 

Phrase: "Rudolf Juliano"

Phrase: "(School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "University of North Carolina,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028407:North Carolina [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1709269:North [Spatial Concept]

Phrase: "Chapel Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "NC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; Schreiner et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.33: All cells were maintained in -MEM (Sigma Chemical Co., St. Louis, MO) supplemented with 10% FBS and glutamine/pen-strep (Irvine Scientific, Santa Ana, CA). 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in -MEM (Sigma Chemical Co.,"

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "glutamine/pen-strep (Irvine Scientific, Santa Ana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   818   C1551531:Santa Ana [Population Group]

Phrase: "CA)."
Processing 00000000.tx.34: G418 (GIBCO BRL, Gaithersburg, MD) was added to the media of transfected cells at a concentration of 250g/ml. 

Phrase: "G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(GIBCO BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Gaithersburg,"

Phrase: "MD)"

Phrase: "was"

Phrase: "added to the media of transfected cells"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0009458:Media [Intellectual Product]
   748   C0162867:Media [Tissue]
   748   C1254021:Media [Tissue]
   748   C1524062:Added [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1705217:Medium [Substance]
   714 E C1883712:Add [Functional Concept]
   714 E C1948049:Cell [Spatial Concept]
   714 E C3244283:medium [Intellectual Product]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 250g/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.35: Reagents Amyloid beta 1-40peptide (A) was synthesized as previously described (Nordstedt et al., 1994). 

Phrase: "Reagents Amyloid beta 1-40peptide"

Phrase: "(A)"

Phrase: "was"

Phrase: "synthesized as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Nordstedt et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.36: A was also purchased from a commercial source (Synthetic Amyloid Beta peptide 1-40; Bachem, Torrance, CA). 

Phrase: "A"

Phrase: "was"

Phrase: "also"

Phrase: "purchased from a commercial source"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449416:Source [Finding]
   760   C0680536:commercial [Intellectual Product]
   760   C0869011:purchased [Activity]
   760   C1705919:Source [Idea or Concept]
   760   C3272563:Commercial [Intellectual Product]

Phrase: "(Synthetic Amyloid Beta peptide 1-40"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   895   C3641227:Amyloid Beta 1-40 [Laboratory Procedure]
           Amyloid Beta 40
   861   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   858   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C0439509:/40 [Temporal Concept]
   799   C1883254:synthetic [Activity]
   799   C2004068:Beta [Qualitative Concept]

Phrase: "; Bachem,"

Phrase: "Torrance,"

Phrase: "CA)."
Processing 00000000.tx.37: A1-40 from both sources was examined for cell adhesion activity. 

Phrase: "A1-40 from both sources"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0439509:/40 [Temporal Concept]
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "was"

Phrase: "examined for cell adhesion activity."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0007577:Cell Adhesion [Cell Function]
   760   C0001511:Adhesion [Pathologic Function]
   760   C0007634:Cell [Cell]
   760   C0175633:Adhesion [Natural Phenomenon or Process]
   760   C0205177:Activity [Functional Concept]
   760   C0332128:Examined [Finding]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1269647:Cell [Cell]
   760   C1561536:*Activity [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.38: Two out of the three Bachem lots tested showed adhesive activity (lots zn571 and wm365), while lot zn327 was not active. 

Phrase: "Two out of the three Bachem lots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "adhesive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(lots zn571"

Phrase: "and"

Phrase: "wm365"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "lot zn327"

Phrase: "was"

Phrase: "not active."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]
Processing 00000000.tx.39: For water-free storage to prevent aggregation of A into its fibrillar form, the peptide was dissolved and stored in 1,1,1,3,3,3,-hexafluoro-2-propanol (HFIP; Fluka Chemika, Neu-Ulm, Switerland). 

Phrase: "For water-free storage to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337174:Storage [Spatial Concept]
   812   C1698986:Storage [Functional Concept]
   812   C1753314:storage [Cell Component]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "aggregation of A into its fibrillar form,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "dissolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "stored in 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3,-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "hexafluoro-2-propanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0062622:hexafluoro-2-propanol [Organic Chemical]
   827   C0001964:Propanol [Organic Chemical,Pharmacologic Substance]
   827   C0175804:Propanol [Organic Chemical]

Phrase: "(HFIP"

Phrase: "; Fluka Chemika,"

Phrase: "Neu-Ulm,"

Phrase: "Switerland"

Phrase: ")."
Processing 00000000.tx.40: Before use, the peptide was lyophilized from HFIP, dissolved in sterile distilled water at 1mg/ml, and tested immediately. 

Phrase: "Before use,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "lyophilized from HFIP,"

Phrase: "dissolved in sterile distilled water"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   797   C0359299:sterile water [Inorganic Chemical,Pharmacologic Substance]
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0232920:Sterile [Qualitative Concept]
   760   C0599638:WATER [Substance]
   760   C0678108:Sterile [Pathologic Function]
   760   C0681549:distilled [Occupational Activity]
   760   C1550678:Water [Inorganic Chemical]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "at 1mg/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "immediately."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]
Processing 00000000.tx.41: The control peptide, A40-1, was purchased from Bachem, solubilized in water at 1mg/ml, and tested immediately. 

Phrase: "The control peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "A40-1,"

Phrase: "was"

Phrase: "purchased from Bachem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "solubilized in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "at 1mg/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "immediately."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]
Processing 00000000.tx.42: Fibronectin was purchased from Chemicon International, Inc. 

Phrase: "Fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "purchased from Chemicon International, Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0869011:purchased [Activity]
   760   C1512888:International [Idea or Concept]
Processing 00000000.tx.43: (Temecula, CA), and vitronectin was purified as described (Yatohgo et al., 1988). 

Phrase: "(Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA),"

Phrase: "and"

Phrase: "vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "was"

Phrase: "purified as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "(Yatohgo et al.,"

Phrase: "1988"

Phrase: ")."
Processing 00000000.tx.44: Purified anti-human 5 integrin monoclonal antibody (P1D6; Calbiochem-Novabiochem Corp., La Jolla, CA; Wayner et al., 1988) and purified mouse IgG (Sigma Chemical Co.) were used at a concentration of 50g/ml. 

Phrase: "Purified anti-human 5 integrin monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0746619:monoclonal [Finding]

Phrase: "(P1D6"

Phrase: "; Calbiochem-Novabiochem Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA"

Phrase: "; Wayner et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: "and"

Phrase: "purified mouse IgG (Sigma Chemical Co.)"

Phrase: "were"

Phrase: "used at a concentration of 50g/ml."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C1524063:Use of [Functional Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0439526:/mL [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1446561:Concentration [Quantitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.45: Transfection The CHO-B2/51+, CHO-B2/v1+, and IMR-32/51+ cells were generated by introducing cDNAs coding for the 5 and v integrin subunits into 51-deficient CHO-B2 and IMR-32 cells (Schreiner et al., 1989; Bauer et al., 1992; Zhang et al., 1993, 1995). 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "The CHO-B2/51+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0507114:B2 [Body Part, Organ, or Organ Component]
   827   C1416271:B2 [Gene or Genome]

Phrase: "CHO-B2/v1+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0457422:V1 [Finding]
   827   C0507238:V1 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "IMR-32/51+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "generated by introducing cDNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3146294:Generated [Activity]
   737   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1292748:introduce [Functional Concept]

Phrase: "coding for the 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009219:Coding [Occupational Activity]
   737 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "v integrin subunits into 51-deficient CHO-B2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "IMR-32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Schreiner et al.,"

Phrase: "1989"

Phrase: "; Bauer et al.,"

Phrase: "1992"

Phrase: "; Zhang et al.,"

Phrase: "1993,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.46: Transfectants expressing the integrin were cloned and expanded (Zhang et al., 1993; Zhang et al., 1995). 

Phrase: "Transfectants"

Phrase: "expressing"

Phrase: "the integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "were"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "(Zhang et al.,"

Phrase: "1993"

Phrase: "; Zhang et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.47: CHO-B2 and IMR-32 control cells received the empty vector. 

Phrase: "CHO-B2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507114:B2 [Body Part, Organ, or Organ Component]
   861   C1416271:B2 [Gene or Genome]

Phrase: "and"

Phrase: "IMR-32 control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.48: Integrin Analysis Integrin expression of IMR-32 and CHO transfectants was analyzed by FACS using monoclonal antibodies against human 5 (P1D6), v (L230), and 1 (P4C10). 

Phrase: "Integrin Analysis Integrin expression of IMR-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CHO transfectants"

Phrase: "was"

Phrase: "analyzed by FACS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal antibodies against human 5"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0746619:monoclonal [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(P1D6"

Phrase: ")"

Phrase: ","

Phrase: "v (L230"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(P4C10"

Phrase: ")."
Processing 00000000.tx.49: FITC-conjugated goat anti-mouse antibody (Sigma Chemical Co.) was used as the secondary antibody. 

Phrase: "FITC-conjugated goat anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma Chemical Co.)"

Phrase: "was"

Phrase: "used as the secondary antibody."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: The same integrin antibodies were used to block integrin function in other experiments. 

Phrase: "The same integrin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "integrin function in other experiments."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.51: Cell Adhesion to Nonfibrillar A1-40 The cell attachment assay and the use of antibodies and peptides as inhibitors of adhesion have been described previously (Zhang et al., 1993; Matter and Laurie, 1994). 

Phrase: "Cell Adhesion to Nonfibrillar A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "The cell attachment assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0887869:Cell Attachment [Cell Component]

Phrase: "and"

Phrase: "the use of antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "peptides as inhibitors of adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Zhang et al.,"

Phrase: "1993"

Phrase: "; Matter"

Phrase: "and"

Phrase: "Laurie,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.52: Microtiter plates coated overnight at room temperature with nonfibrillar A1-40 peptide, control A40-1 peptide, or fibronectin were blocked with 1% BSA for 30min at room temperature, the wells were rinsed once with PBS (pH 7.4), and cells were subsequently added (2105cells/well) in serum-free media and incubated for 60min (37C). 

Phrase: "Microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C1709027:Microtiter Plate [Research Device]
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "overnight at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "with nonfibrillar A1-40 peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "control A40-1 peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "blocked with 1% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "for 30min"

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "once with PBS (pH 7.4"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1882074:pH 7 [Qualitative Concept]
   783   C2678549:PH-4 [Gene or Genome]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1720092:Once [Intellectual Product]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]
   753   C1948045:Once [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(2105cells/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "in serum-free media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C1254021:Media [Tissue]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubated for 60min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(37C"

Phrase: ")."
Processing 00000000.tx.53: Inhibition studies were performed by preincubating cells with antibody for 30min (37C; gentle agitation every 10min), and then cells including antibodies were added to the coated wells. 

Phrase: "Inhibition studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed by preincubating cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0007634:Cells [Cell]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for 30min"

Phrase: "(37C"

Phrase: "; gentle agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085631:Agitation [Sign or Symptom]

Phrase: "every 10min"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "added to the coated wells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C1522408:Coated [Qualitative Concept]
   760   C1524062:Added [Functional Concept]
   726   C0205170:Well [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1883712:Add [Functional Concept]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
   726   C3146287:Well [Manufactured Object]
Processing 00000000.tx.54: After a 60-min incubation at 37C, plates were gently washed four times with PBS, fixed with 1% glutaraldehyde (Sigma Chemical Co.), PBS-washed once, stained with 0.5% crystal violet, 20% MEOH, washed under running distilled water, solubilized in 0.1N sodium citrate, 50% ETOH, and read on an ELISA plate reader (Molecular Devices Corp., Sunnyvale, CA) using the 590-nm filter. 

Phrase: "After a 60-min incubation"

Phrase: "at 37C,"

Phrase: "plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "gently washed four times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "fixed with 1% glutaraldehyde"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]
   715 E C0878318:Cidex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Sigma Chemical Co."

Phrase: ")"

Phrase: ","

Phrase: "PBS-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "stained with 0.5% crystal violet,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   804   C0017440:Crystal violet stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Crystal Violet
   790   C0444499:0/5 [Quantitative Concept]
   753   C0330463:Violet [Plant]
   753   C0427896:Crystal [Body Substance]
   753   C0444626:Crystal [Chemical Viewed Structurally]
   753   C0678580:violet [Natural Phenomenon or Process]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "20% MEOH,"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "under running"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0035953:Running [Daily or Recreational Activity]
   861   C0542339:Under [Spatial Concept]
   861   C2346414:Running [Finding]
   827 E C0600140:run [Finding]
   827 E C1704688:Run [Functional Concept]

Phrase: "distilled water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "solubilized in 0.1N sodium citrate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   753   C0008857:Citrate [Organic Chemical]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "50% ETOH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:ETOH [Organic Chemical]

Phrase: "and"

Phrase: "read on an ELISA plate reader"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005971:Plate [Medical Device]
   753   C0014441:ELISA [Laboratory Procedure]
   753   C0034754:Read [Daily or Recreational Activity]
   753   C1139930:plate [Medical Device]
   753   C1514743:Reader [Professional or Occupational Group]
   753   C1705179:read [Finding]
   753   C1706461:Reader [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]

Phrase: "(Molecular Devices Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Sunnyvale,"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 590-nm filter."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0180860:Filter [Manufactured Object]
   827   C0581406:Filter [Medical Device]
   827   C1522664:Filter [Intellectual Product]
   827   C1704449:Filter [Conceptual Entity]
   827   C1704684:Filter [Medical Device]
   827   C1875155:FILTER [Medical Device]
Processing 00000000.tx.55: Adhesion assays with fibrillar A1-40 were performed as above. 

Phrase: "Adhesion assays with fibrillar A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as above."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.56: Before the adhesion assay, soluble A1-40 was incubated at 4C for 96h to allow self-aggregation of A1-40 into its fibrillar form (Jarret et al., 1993). 

Phrase: "Before the adhesion assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "soluble A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439509:/40 [Temporal Concept]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 96h to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "self-aggregation of A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "into its fibrillar form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(Jarret et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.57: Coating efficiency was measured by coating microtiter wells with either soluble [125I]A1-40 or preaggregated [125I]A1-40 at room temperature overnight. 

Phrase: "Coating efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "was"

Phrase: "measured by coating microtiter wells"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0444706:Measured [Qualitative Concept]
   760   C1522408:Coating [Qualitative Concept]
   760   C1704806:Coating [Biomedical or Dental Material]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726   C0205170:Well [Qualitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C3146287:Well [Manufactured Object]

Phrase: "with either soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "[125I"

Phrase: "]A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "or"

Phrase: "preaggregated"

Phrase: "[125I"

Phrase: "]A1-40 at room temperature overnight."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C1547703:Room [Spatial Concept]
Processing 00000000.tx.58: Nonbound peptide solution was removed, and the well and the nonbound peptide solution were counted. 

Phrase: "Nonbound peptide solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "the nonbound peptide solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.59: Both forms of A1-40 bound to the wells with an efficiency of ~70%. 

Phrase: "Both"

Phrase: "forms of A1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0439509:/40 [Temporal Concept]
   770   C1522492:Form [Functional Concept]

Phrase: "bound to the wells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737   C0205170:Well [Qualitative Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "with an efficiency of ~70%."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.60: Immunostaining of A Fibrillar Matrix Cells were plated on four-well PermanoxTM plastic slides (Nunc Inc., Naperville, IL) at 50,000cells/well. 

Phrase: "Immunostaining of A Fibrillar Matrix Cells"

Phrase: "were"

Phrase: "plated on four-well PermanoxTM plastic slides"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0032167:Plastic [Substance]
   748   C0205170:Well [Qualitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0444330:slides [Research Device]
   748   C3146287:Well [Manufactured Object]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714 E C1705201:Slide [Manufactured Object]
   714   C3537155:Plate [Manufactured Object]

Phrase: "(Nunc Inc.,"

Phrase: "Naperville,"

Phrase: "IL) at 50,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020898:IL [Geographic Area]
   790   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0022271:IL [Geographic Area]

Phrase: "000cells/well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]
Processing 00000000.tx.61: 6h after plating, the media was replaced with media containing A1-40 peptide (100 g/ml) and incubated for 72h at 37C. 

Phrase: "6h after plating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C0559956:Replaced [Functional Concept]
   790   C1254021:Media [Tissue]
   790   C1299987:replaced [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1554078:Replace [Idea or Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "A1-40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(100 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.62: The cultures were washed with PBS and fixed in PBS containing 3.7% paraformaldehyde and 10mM sucrose, pH 7.4,for 30min at room temperature. 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "fixed in PBS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C2827483:Fixed [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3.7% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 30min"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.63: The cultures were then blocked with 1% BSA/PBS and stained with a polyclonal rabbit anti-human A1-40 peptide antibody (Chemicon International, Inc.) for 2h, followed by goat anti-rabbit FITC-labeled IgG (Sigma Chemical Co.) secondary antibody. 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "blocked with 1% BSA/PBS"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "stained with a polyclonal rabbit anti-human A1-40 peptide antibody"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0368589:A1 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0432617:Anti-A1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0034493:Rabbit [Mammal]
   738   C0086418:Human [Human]
   738   C0439509:/40 [Temporal Concept]
   738   C2986582:Stained [Qualitative Concept]
   704 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Chemicon International, Inc.) for 2h,"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "by goat anti-rabbit FITC-labeled IgG (Sigma Chemical Co.) secondary antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   880   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   870   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C2754943:IgG antibody [Cell Component]
   788   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   788   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.64: After antibody treatment, coverslips were mounted with Vectashield mounting medium (Vector Labs., Inc., Burlingame, CA) and analyzed under a fluorescent confocal microscope. 

Phrase: "After antibody treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "coverslips"

Phrase: "were"

Phrase: "mounted with Vectashield mounting medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0449878:mounted [Finding]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0181909:Mount [Medical Device]

Phrase: "(Vector Labs.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0587081:Labs [Finding]
   827 E C0022877:Lab [Manufactured Object,Organization]
   789 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "Inc.,"

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "and"

Phrase: "analyzed under a fluorescent confocal microscope."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1626420:Confocal microscope [Medical Device]
   753   C0181839:Microscope [Medical Device]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1706379:Microscope [Medical Device]
Processing 00000000.tx.65: Analysis of A in Matrix Deposition with Radiolabeled [125I]A 125I-labeled A1-40 peptide was purchased as a lyophilized powder (25Ci) from Nycomed Amersham, Inc. 

Phrase: "Analysis of A in Matrix Deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with Radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[125I"

Phrase: "]"

Phrase: "A 125I-labeled A1-40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "purchased as a lyophilized powder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2981265:Powder, Lyophilized [Biomedical or Dental Material]
   760   C0032861:Powder [Biomedical or Dental Material]
   760   C0869011:purchased [Activity]
   760   C1382110:Powder [Substance]

Phrase: "(25Ci"

Phrase: ")"

Phrase: "from Nycomed Amersham,"

Phrase: "Inc."
Processing 00000000.tx.66: (Princeton, NJ). 

Phrase: "(Princeton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331889:Princeton [Health Care Related Organization]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.67: The powder was solubilized in sterile water and immediately added to 24-well culture dishes at a concentration of 2ng/well. 

Phrase: "The powder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032861:Powder [Biomedical or Dental Material]
  1000   C1382110:Powder [Substance]

Phrase: "was"

Phrase: "solubilized in sterile water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0359299:sterile water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0232920:Sterile [Qualitative Concept]
   770   C0599638:WATER [Substance]
   770   C0678108:Sterile [Pathologic Function]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "added to 24-well culture dishes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0010453:Culture [Idea or Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1524062:Added [Functional Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   719   C0020498:DISH [Disease or Syndrome]
   719 E C1883712:Add [Functional Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2ng/well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]
Processing 00000000.tx.68: The specific activity of the 125I-labeled A1-40 peptide was 2106 Ci/mmol. 

Phrase: "The specific activity of the 125I-labeled A1-40 peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0205177:Activity [Functional Concept]
   739   C0205369:Specific [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1552740:specific [Intellectual Product]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "2106 Ci/mmol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.69: Insolubilization of A was analyzed using 125I-labeled A1-40 peptide as described previously for fibronectin matrix assembly (McKeown-Longo and Mosher, 1985; Morla and Ruoslahti, 1992). 

Phrase: "Insolubilization of A"

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "125I-labeled A1-40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for fibronectin matrix assembly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "(McKeown-Longo"

Phrase: "and"

Phrase: "Mosher,"

Phrase: "1985"

Phrase: "; Morla"

Phrase: "and"

Phrase: "Ruoslahti,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.70: Cells were plated at 105 cells/ml (IMR variants) or 0.5105 cells/ml (CHO variants) into 24-well tissue culture plates in media containing 10% serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at 105 cells/ml (IMR variants"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C2699156:Cells/mL [Quantitative Concept]
   757   C1166718:cells plate [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0205419:variants [Qualitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "0.5105 cells/ml (CHO variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:variants [Qualitative Concept]

Phrase: ")"

Phrase: "into 24-well tissue culture plates"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   840   C0040284:Tissue culture [Laboratory Procedure]
   840   C0180454:culture plates [Medical Device]
   804   C0010453:Culture [Idea or Concept]
   804   C0040300:Tissue [Tissue]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1139930:plates [Medical Device]
   804   C1547928:Tissue [Intellectual Product]
   804   C2242979:Culture [Laboratory Procedure]
   771 E C0005971:Plate [Medical Device]
   771 E C3537155:Plate [Manufactured Object]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.71: Media was replaced 6h after plating with media containing [125I]A1-40 and 10% serum. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "6h after plating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "with media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "[125I"

Phrase: "]A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.72: Cells were cultured for 72h at 37C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 72h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1292423:72H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.73: The media was then removed, the wells were washed three times with PBS, and 5 SDS sample buffer (0.5M Tris pH 6.8,glycerol, 10% SDS, 0.5% bromophenol blue) was used to solubilize the [125I]A matrix in each well. 

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "5 SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.5M Tris pH 6.8,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "10% SDS,"

Phrase: "0.5% bromophenol blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromophenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "solubilize"

Phrase: "the [125I"

Phrase: "]"

Phrase: "A matrix in each well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.74: For antibody inhibition experiments, cells were plated as above. 

Phrase: "For antibody inhibition experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated as above."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.75: 6h after plating, the media was replaced with media containing the appropriate antibody and 10% serum. 

Phrase: "6h after plating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C0559956:Replaced [Functional Concept]
   790   C1254021:Media [Tissue]
   790   C1299987:replaced [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1554078:Replace [Idea or Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the appropriate antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.76: 125I-labeled A1-40 peptide (2ng/well) was added to the antibody-containing media and incubated for 72h at 37C. 

Phrase: "125I-labeled A1-40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(2ng/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "added to the antibody-containing media"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0009458:Media [Intellectual Product]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0162867:Media [Tissue]
   753   C0332256:Containing [Functional Concept]
   753   C1254021:Media [Tissue]
   753   C1524062:Added [Functional Concept]
   753   C2700400:Containing [Activity]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C1883712:Add [Functional Concept]
   719 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.77: The cells were then processed as above. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "processed as above."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.78: Internalization and Degradation of [125I]Soluble A1-40 Internalization of A1-40 added to cell layers was measured as described (Duckworth et al., 1972; McDermott and Gibson, 1997). 

Phrase: "Internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "Degradation of [125I"

Phrase: "]Soluble A1-40 Internalization of A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871786:internalization [Mental Process]

Phrase: "added to cell layers"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0934502:layers [Body Part, Organ, or Organ Component]
   770   C1269647:Cell [Cell]
   770   C1524062:Added [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1522408:Layer [Qualitative Concept]
   737 E C1561599:Layer [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(Duckworth et al.,"

Phrase: "1972"

Phrase: "; McDermott"

Phrase: "and"

Phrase: "Gibson,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.79: Subconfluent cells were trypsinized and plated onto 24-well plates. 

Phrase: "Subconfluent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "trypsinized"

Phrase: "and"

Phrase: "plated onto 24-well plates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205170:Well [Qualitative Concept]
   760   C1139930:plates [Medical Device]
           plate
   760   C3146287:Well [Manufactured Object]
   726   C0005971:Plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.80: Media was replaced 6h after plating with [125I]A1-40 (2ng/ml). 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "6h after plating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "with"

Phrase: "[125I"

Phrase: "]A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "(2ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: The cells were incubated for 1h with [125I]A1-40, the media was removed, cells were washed five times with PBS, and serum-containing media containing no A1-40 was added. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "with"

Phrase: "[125I"

Phrase: "]A1-40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "serum-containing media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C0229671:Serum [Body Substance]
   827   C0332256:Containing [Functional Concept]
   827   C1254021:Media [Tissue]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2700400:Containing [Activity]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.82: The cells were cultured for 1to 12h at 37C, washed three times with PBS, detached by EDTA, washed twice with PBS, lysed in 100l of 1% NP40 buffer for 10min at 4C, and lysate-analyzed for radioactivity. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 1to 12h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0456695:/12h [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "at 37C,"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "detached by EDTA,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]
   718 E C0541879:detachment [Mental Process]
   718 E C0595950:Detachment [Pathologic Function]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "lysed in 100l of 1% NP40 buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:lysed [Pathologic Function]

Phrase: "for 10min"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "lysate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "analyzed for radioactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.83: For TCA precipitations, the cells were cultured for 72h with [125I]A1-40 at 37C, washed three times with PBS, detached by EDTA, washed twice with PBS, and lysed in 100l of 1% NP40 buffer for 10min at 4C. 

Phrase: "For TCA precipitations,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0032931:Precipitation [Natural Phenomenon or Process]
   793   C0032932:Precipitation [Molecular Function]
   793   C1642401:% precipitation [Quantitative Concept]
   793   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 72h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1292423:72H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "with"

Phrase: "[125I"

Phrase: "]A1-40 at 37C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439509:/40 [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "detached by EDTA,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]
   718 E C0541879:detachment [Mental Process]
   718 E C0595950:Detachment [Pathologic Function]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "lysed in 100l of 1% NP40 buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:lysed [Pathologic Function]

Phrase: "for 10min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.84: BSA/ PBS (100l, 1%) was added to the samples, the samples were vortexed, and 1.6ml of TCA (12.5% wt/vol) was added with vortexing. 

Phrase: "BSA/ PBS (100l,"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "added to the samples,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1883712:Add [Functional Concept]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "1.6ml of TCA"

Phrase: "(12.5% wt/vol)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449468:VOL [Quantitative Concept]
   812   C0560268:vol% [Quantitative Concept]
   812   C1690016:% vol [Qualitative Concept]

Phrase: "was"

Phrase: "added with vortexing."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0439648:vortexing [Spatial Concept]
   790   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]
   756 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.85: The samples were centrifuged at 2,000rpm for 10min at 4C, and the supernatant and pellet were collected for radioactive counting. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "000rpm for 10min"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "collected for radioactive counting."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034553:radioactive [Natural Phenomenon or Process]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.86: Secretion of 125I-Labeled A1-40 Subconfluent cells were detached with trypsin, washed once with media, and plated at 105 cells/ml in 24-well plates. 

Phrase: "Secretion of 125I-Labeled A1-40 Subconfluent cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C1327616:Cell secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "were"

Phrase: "detached with trypsin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with media,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "plated at 105 cells/ml"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C2699156:Cells/mL [Quantitative Concept]
   781   C1166718:cells plate [Cell Component]
   760   C0007634:Cells [Cell]
   760   C0439526:/mL [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726   C0005971:Plate [Medical Device]
   726   C1139930:plate [Medical Device]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C3537155:Plate [Manufactured Object]

Phrase: "in 24-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.87: 6h after plating, media was replaced with 2ng/ml of [125I]A1-40 in serum-containing media and incubated for 1h at 37C. 

Phrase: "6h after plating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with 2ng/ml of [125I"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0439526:/mL [Quantitative Concept]
   753   C0559956:Replaced [Functional Concept]
   753   C1299987:replaced [Functional Concept]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "]A1-40 in serum-containing media"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0009458:Media [Intellectual Product]
   753   C0162867:Media [Tissue]
   753   C0229671:Serum [Body Substance]
   753   C0332256:Containing [Functional Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1254021:Media [Tissue]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2700400:Containing [Activity]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.88: The radiolabeled media was removed, and cells were washed five times in PBS before serum-containing media containing no A was added to each well. 

Phrase: "The radiolabeled media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times in PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "before serum-containing media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C0229671:Serum [Body Substance]
   827   C0332256:Containing [Functional Concept]
   827   C1254021:Media [Tissue]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2700400:Containing [Activity]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no A"

Phrase: "was"

Phrase: "added to each well."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.89: At designated time points, 100l of media was collected, and [125I] was measured. 

Phrase: "At designated time points,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "100l of media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and ["

Phrase: "125I"

Phrase: "]"

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.90: Apoptosis and Cell Viability Assays The apoptotic effect of fibrillar A was determined using the Apoptag Plus In Situ Apoptosis KitTM (Oncor, Inc., Gaithersburg, MD) that detects the 3'-OH region of cleaved DNA. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "Cell Viability Assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0007620:Cell Viability [Cell Function]

Phrase: "The apoptotic effect of fibrillar A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Apoptag Plus In Situ Apoptosis KitTM"

Phrase: "(Oncor,"

Phrase: "Inc.,"

Phrase: "Gaithersburg,"

Phrase: "MD)"

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the 3'-OH region of cleaved DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
Processing 00000000.tx.91: Cells were plated on eight-chamber tissue culture glass slides (Miles Scientific Laboratories, Inc., Naperville, IL), and 6h after plating the media was replaced with media containing either A1-40 peptide (50g/ml) or A40-1 control peptide (50g/ml) and 10% serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on eight-chamber tissue culture glass slides"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   778   C0492791:CHAMBER, SLIDE CULTURE [Medical Device]
   770   C0040284:Tissue culture [Laboratory Procedure]
   750   C0180454:Culture plate [Medical Device]
   744   C0010453:Culture [Idea or Concept]
   744   C0017596:Glass [Manufactured Object]
   744   C0040300:Tissue [Tissue]
   744   C0205454:Eight [Quantitative Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0444330:slides [Research Device]
   744   C0935616:Chamber [Body Part, Organ, or Organ Component]
   744   C1547928:Tissue [Intellectual Product]
   744   C1947936:Glass [Medical Device]
   744   C2242979:Culture [Laboratory Procedure]
   711   C0005971:Plate [Medical Device]
   711   C1139930:plate [Medical Device]
   711 E C1705201:Slide [Manufactured Object]
   711   C3537155:Plate [Manufactured Object]

Phrase: "(Miles Scientific Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Naperville,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "6h after plating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C0559956:Replaced [Functional Concept]
   790   C1254021:Media [Tissue]
   790   C1299987:replaced [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1554078:Replace [Idea or Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either A1-40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(50g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "A40-1 control peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(50g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.92: Cells were cultured for 72h at 37C, and were then fixed in a solution containing 3.7% paraformaldehyde, 10mM sucrose in PBS for 30min at room temperature. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 72h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1292423:72H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed in a solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037633:Solution [Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C2827483:Fixed [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3.7% paraformaldehyde,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "10mM sucrose in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "for 30min"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.93: Cells were stained following kit protocol, counterstained with propidium iodide/antifade solution (Oncor, Inc.), mounted, and viewed under a confocal microscope. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "kit protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "counterstained with propidium iodide/antifade solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0021966:Iodide [Inorganic Chemical]
   753   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Oncor,"

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: ","

Phrase: "and"

Phrase: "viewed under a confocal microscope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1626420:Confocal microscope [Medical Device]
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   726   C0449911:View [Spatial Concept]
Processing 00000000.tx.94: To measure apoptosis by nuclear fragmentation, cells were plated in wells coated with either 50g/ml of fibronectin, vitronectin, or A1-40 for 72h in serum-free medium. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "apoptosis by nuclear fragmentation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1818658:apoptotic nuclear fragmentation [Cell Function]
   770   C0162638:Apoptosis [Cell Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in wells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0005971:Plate [Medical Device]
   756   C0205170:Well [Qualitative Concept]
   756   C1139930:plate [Medical Device]
   756   C3146287:Well [Manufactured Object]
   756   C3537155:Plate [Manufactured Object]

Phrase: "coated with either 50g/ml of fibronectin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "vitronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "or"

Phrase: "A1-40 for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C1292423:72H [Temporal Concept]

Phrase: "in serum-free medium."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]
Processing 00000000.tx.95: Attached and floating cells were then collected by centrifugation, washed once with PBS, fixed with 3.7% paraformaldehyde for 10min at room temperature, and stained with 0.1g of 4', 6-diamidino-2-phenylindole (DAPI) per ml in PBS. 

Phrase: "Attached"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231441:Attached [Finding]
   966 E C1314972:ATTACH [Intellectual Product]

Phrase: "and"

Phrase: "floating cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected by centrifugation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "fixed with 3.7% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "for 10min"

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "stained with 0.1g of 4',"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "6-diamidino-2-phenylindole (DAPI) per ml"

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.96: The stained cells were washed three times with PBS and mounted onto slides for analysis under a fluorescence microscope (Zhang et al., 1995). 

Phrase: "The stained cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "mounted onto slides"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444330:slides [Research Device]
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]
   756 E C1705201:Slide [Manufactured Object]

Phrase: "for analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "under a fluorescence microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Zhang et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.97: Cell viability was assessed in several assays. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed in several assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1516048:Assessed [Activity]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.98: The ability of cells to take up acridine orange/ethidium bromide was measured as described (Cotter and Martin, 1996). 

Phrase: "The ability of cells to take up acridine orange/ethidium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0085732:Ability [Organism Attribute]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(Cotter"

Phrase: "and"

Phrase: "Martin,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.99: In brief, the assay was performed in 96-well tissue culture plates containing 100l media/well. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in 96-well tissue culture plates"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0040284:Tissue culture [Laboratory Procedure]
   778   C0180454:culture plates [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0884358:Performed [Functional Concept]
   748   C1139930:plates [Medical Device]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714 E C0005971:Plate [Medical Device]
   714 E C2947996:Perform [Pharmacologic Substance]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100l media/well."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C0205170:Well [Qualitative Concept]
   827   C1254021:Media [Tissue]
   827   C3146287:Well [Manufactured Object]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.100: Cells were plated in media containing 10% serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in media"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756   C0005971:Plate [Medical Device]
   756 E C0439536:Medium [Quantitative Concept]
   756   C1139930:plate [Medical Device]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]
   756   C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.101: 6h after plating, the media was replaced with media containing various concentrations of the test reagents and 10% serum. 

Phrase: "6h after plating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292428:6H [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C0559956:Replaced [Functional Concept]
   790   C1254021:Media [Tissue]
   790   C1299987:replaced [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1554078:Replace [Idea or Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "various concentrations of the test reagents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "10% serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.102: The plates were incubated for 72h at 37C. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.103: At the 72-h time point, cells were trypsinized and resuspended in PBS at 0.5106 cells/ml. 

Phrase: "At the 72-h time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "trypsinized"

Phrase: "and"

Phrase: "resuspended in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "at 0.5106 cells/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2699156:Cells/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.104: 1l from a solution of acridine orange (100g/ml) and ethidium bromide (100g/ml) was added to a 25-l cell suspension, incubated for 2min at room temperature, and examined under 40 magnification using a Zeiss Fluorescence microscope. 

Phrase: "1l from a solution of acridine orange"

Phrase: "(100g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "(100g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to a 25-l cell suspension,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0022827:L cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0038960:Suspension [Biomedical or Dental Material]
   748   C1269647:Cell [Cell]
   748   C1382107:Suspension [Substance]
   748   C1524062:Added [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1705537:Suspension [Functional Concept]
   748   C1948049:Cell [Spatial Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "incubated for 2min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "examined under 40 magnification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332128:Examined [Finding]
   770   C0439509:/40 [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Zeiss Fluorescence microscope."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.105: Cells cultured in microtiter wells were pulsed with 25l of a 2.5mg/ml MTT stock in PBS and incubated for 4h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in microtiter wells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0010453:Culture [Idea or Concept]
   737   C0205170:Well [Qualitative Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]
   737   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "pulsed with 25l of a 2.5mg/ml MTT stock"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   739   C0439526:/mL [Quantitative Concept]
   739   C0647210:mtt [Lipid]
   739   C1710198:Stock [Idea or Concept]
   739   C1947910:Pulsed [Phenomenon or Process]
   706 E C0232117:PULSE [Clinical Attribute]
   706 E C0391850:Pulse [Physiologic Function]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "incubated for 4h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292426:4H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.106: Then 100 l of a solution containing 10% SDS, 0.01N HCl was added, and the plates were incubated overnight (Tada et al., 1986). 

Phrase: "Then 100 l of a solution"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% SDS,"

Phrase: "0.01N HCl"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "(Tada et al.,"

Phrase: "1986"

Phrase: ")."
Processing 00000000.tx.107: Absorption was read on a Vmax Microplate ReaderTM (Molecular Devices Corp., Sunnyvale, CA) using a reference wavelenth of 650nm and a test wavelength of 590nm. 

Phrase: "Absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0000854:Absorption [Natural Phenomenon or Process]
  1000   C0220777:absorption [Functional Concept]
  1000   C2347023:Absorption [Phenomenon or Process]
  1000   C2347080:Absorption [Phenomenon or Process]
  1000   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
  1000   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "read on a Vmax Microplate ReaderTM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034754:Read [Daily or Recreational Activity]
   753   C1705179:read [Finding]
   753   C1709027:Microplate [Research Device]
   753   C1710637:Vmax [Phenomenon or Process]

Phrase: "(Molecular Devices Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Sunnyvale,"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a reference wavelenth of 650nm"

Phrase: "and"

Phrase: "a test wavelength of 590nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449819:Wavelength [Quantitative Concept]
Processing 00000000.tx.108: Test reagents were added to media alone in order to provide a blank. 

Phrase: "Test reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "added to media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   790   C1524062:Added [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C1883712:Add [Functional Concept]
   756 E C3244283:medium [Intellectual Product]

Phrase: "alone in order to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a blank."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750479:blank [Finding]
Processing 00000000.tx.109: To measure lactate dehydrogenase (LDH) release from cells, the colorimetric Cytotox 96-LDH-Release AssayTM (Promega Corp., Madison, WI) was performed according to the instructions of the manufacturer.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "lactate dehydrogenase (LDH) release from cells,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the colorimetric Cytotox 96-LDH-Release AssayTM"

Phrase: "(Promega Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Madison,"

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "was"

Phrase: "performed according to the instructions of the manufacturer."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0302828:instructions [Intellectual Product]
   744   C0680240:according [Social Behavior]
   744   C0884358:Performed [Functional Concept]
   744   C0947322:Manufacturer [Intellectual Product]
   744   C1442085:Instructions [Idea or Concept]
   744   C1705426:Manufacturer [Population Group]
   744   C3263700:Instructions [Clinical Attribute]
   711 E C0039401:Instruction [Educational Activity]
   711 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.110: Results Top Abstract Introduction Materials & Methods Results Discussion References The Integrin 51 Mediates Cell Adhesion to Nonfibrillar A1-40 The RHD sequence in A resembles the integrin recognition sequence RGD, and has been implicated in cell adhesion to A via one or more of the 1 integrins (Ghiso et al., 1992; Sabo et al., 1995). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The Integrin 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "Mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "Cell Adhesion to Nonfibrillar A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "The RHD sequence in A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "resembles"

Phrase: "the integrin recognition sequence RGD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2699006:RGD [Intellectual Product]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "implicated"

Phrase: "in cell adhesion to A via one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "more of the 1 integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0205172:More [Functional Concept]

Phrase: "(Ghiso et al.,"

Phrase: "1992"

Phrase: "; Sabo et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.111: We set out to determine which of the RGD-binding integrins bind to A. 

Phrase: "We"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "determine"

Phrase: "which of the RGD-binding integrins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1149503:Integrin Binding [Molecular Function]
   753   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C2699006:RGD [Intellectual Product]

Phrase: "bind to A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
Processing 00000000.tx.112: A CHO cell line deficient in 5 integrin subunit expression (CHO-B2) was transfected with cDNA encoding human 5, v, or vector alone, and was examined for its ability to adhere to a surface coated with A1-40. 

Phrase: "A CHO cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C0085080:CHO cell [Cell]

Phrase: "deficient in 5 integrin subunit expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011155:Deficient [Functional Concept]
   753   C1636779:% deficient [Quantitative Concept]

Phrase: "(CHO-B2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507114:B2 [Body Part, Organ, or Organ Component]
   861   C1416271:B2 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "transfected with cDNA encoding human 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086418:Human [Human]
   753   C1547699:Encoding [Idea or Concept]
   753   C2700640:Encoding [Activity]

Phrase: "v,"

Phrase: "or"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "was"

Phrase: "examined for its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0332128:Examined [Finding]

Phrase: "adhere to a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0231441:Adhere [Finding]

Phrase: "surface coated with A1-40."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205148:Surface [Spatial Concept]
   760   C0439509:/40 [Temporal Concept]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.113: Each of the integrin transfectants adhered to A in a dose-dependent manner, but cells that received the vector alone attached to A within the BSA background range (Fig. 1 A). 

Phrase: "Each of the integrin transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C1457900:Each [Quantitative Concept]

Phrase: "adhered to A in a dose-dependent manner,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1512045:Dose-dependent [Quantitative Concept]
   744   C0178602:Dose [Quantitative Concept]
   744   C0231441:Adhered [Finding]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "but"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "attached to A within the BSA background range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0231441:Attached [Finding]
   744   C1514721:Range [Quantitative Concept]
   744   C1706907:Background [Conceptual Entity]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
   711 E C1314972:ATTACH [Intellectual Product]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.114: CHO-B2/51+ cells adhered strongly to A, and CHO-B2/v1+ cells were moderately adhesive, whereas the control cells CHO-B2/c did not adhere above BSA background levels. 

Phrase: "CHO-B2/51+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "adhered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhered [Finding]

Phrase: "strongly to A,"

Phrase: "and"

Phrase: "CHO-B2/v1+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "moderately adhesive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001516:Adhesive [Manufactured Object]
   861   C2982905:Adhesive [Manufactured Object]

Phrase: "whereas"

Phrase: "the control cells CHO-B2/c"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "adhere"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhere [Finding]

Phrase: "above BSA background levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0441889:Levels [Qualitative Concept]
   812   C1706907:Background [Conceptual Entity]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.115: FACS analysis indicated that CHO-B2/51+ and CHO-B2/v1+ cell transfectants were similar in their expression of the transfected integrin (Fig. 2, D and E). 

Phrase: "FACS analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that CHO-B2/51+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0507114:B2 [Body Part, Organ, or Organ Component]
   827   C1416271:B2 [Gene or Genome]

Phrase: "and"

Phrase: "CHO-B2/v1+ cell transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0085080:CHO cell [Cell]

Phrase: "were"

Phrase: "similar in their expression of the transfected integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.116: A control peptide in which the A sequence is inverted (A40-1) did not have adhesive activity with any of the cell types tested (Fig. 1 B). 

Phrase: "A control peptide in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "the A sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "inverted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443241:Inverted [Qualitative Concept]

Phrase: "(A40-1"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "adhesive activity with any of the cell types"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0459205:Type of activity [Intellectual Product]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.117: In addition, integrin transfectants adhered only to soluble nonfibrillar A1-40, and not to fibrillar A1-40 (Fig. 1 B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "integrin transfectants"

Phrase: "adhered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhered [Finding]

Phrase: "only to soluble nonfibrillar A1-40,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205171:Only [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "not to fibrillar A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439509:/40 [Temporal Concept]
   760   C1518422:Not [Functional Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.118: Plates were coated with equal amounts of soluble and fibrillar A1-40 as measured by [125I]A1-40. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "coated with equal amounts of soluble"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205163:Equal [Qualitative Concept]
   753   C1265611:amounts [Quantitative Concept]
   753   C1522408:Coated [Qualitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "fibrillar A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "as"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "[125I"

Phrase: "]A1-40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.119: The 51-mediated cell adhesion to soluble A1-40 was inhibitable by the integrin-binding peptide GRGDSP, and by a function-blocking anti-5 integrin monoclonal antibody (P1D6; Fig. 1 C), but not by the control peptide GRGESP or a monoclonal antibody to v (Fig. 1 C). 

Phrase: "The 51-mediated cell adhesion to soluble A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0007577:Cell Adhesion [Cell Function]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "inhibitable by the integrin-binding peptide GRGDSP,"

Phrase: "and by a function-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1515981:And [Idea or Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "anti-5 integrin monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(P1D6"

Phrase: "; Fig. 1 C),"

Phrase: "but"

Phrase: "not by the control peptide GRGESP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0061710:GRGESP [Amino Acid, Peptide, or Protein]
   753   C0243148:control [Qualitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "a monoclonal antibody to v (Fig. 1 C)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0370124:V Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0746619:monoclonal [Finding]
Processing 00000000.tx.120: The v3 integrin, which also binds to RGD, does not mediate adhesion to A because v3-expressing IMR-90 cells did not adhere to A when the 51 and v1 integrins were blocked with anti-5 and anti-1 monoclonal antibodies (data not shown). 

Phrase: "The v3 integrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "which also"

Phrase: "binds to RGD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C2699006:RGD [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "adhesion to A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001511:Adhesion [Pathologic Function]
   790   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "because"

Phrase: "v3-expressing IMR-90 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "adhere to A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0231441:Adhere [Finding]

Phrase: "when"

Phrase: "the 51"

Phrase: "and"

Phrase: "v1 integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "were"

Phrase: "blocked with anti-5"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "anti-1 monoclonal antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: View larger version (22K): [in this window] [in a new window]  View larger version (16K): [in this window] [in a new window]  View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.123: Integrins mediate CHO cell adhesion to nonfibrillar A. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "CHO cell adhesion to nonfibrillar A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.124: Adhesion of CHO cells to coated A1-40 was measured. 

Phrase: "Adhesion of CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to coated A1-40"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1522408:Coated [Qualitative Concept]
   793 E C0453946:Coat [Manufactured Object]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.125: The cells were transfected with human 5 or v integrin subunit cDNA. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with human 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "or"

Phrase: "v integrin subunit cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.126: (A) The cells were seeded onto various concentrations of coated A1-40. 

Phrase: "(A)"

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded onto various concentrations of coated A1-40."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0086045:Concentrations [Mental Process]
   744   C0439509:/40 [Temporal Concept]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1522408:Coated [Qualitative Concept]
   711   C0036563:Seed [Plant]
   711 E C0453946:Coat [Manufactured Object]
   711 E C1446561:Concentration [Quantitative Concept]
   711   C1705192:Seed [Laboratory Procedure]
   711   C1882540:{Seed} [Quantitative Concept]
   711   C2346495:Seed [Conceptual Entity]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.127: (B) Cells were plated onto A1-40 coated in its soluble form, A1-40 coated after self-aggregation into its fibrillar form, or on the control peptide A40-1. 

Phrase: "(B) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated onto A1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439509:/40 [Temporal Concept]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "coated in its soluble form,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522408:Coated [Qualitative Concept]
   760   C1522492:Form [Functional Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "after"

Phrase: "self-aggregation into its fibrillar form,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "or on the control peptide A40-1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.128: (C) Cells were preincubated with either the blocking monoclonal antibodies to human 5 (P1D6), human v (L230), the integrin-binding peptideGRGDSP, or the control peptide GRGESP, and then seeded onto coated soluble A1-40. 

Phrase: "(C) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0229579:C-Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with either"

Phrase: "the blocking monoclonal antibodies to human 5"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0282682:Antibodies, Blocking [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0746619:monoclonal [Finding]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(P1D6"

Phrase: ")"

Phrase: ","

Phrase: "human v (L230"

Phrase: ")"

Phrase: ","

Phrase: "the integrin-binding peptideGRGDSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1149503:Integrin Binding [Molecular Function]

Phrase: "or"

Phrase: "the control peptide GRGESP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0061710:GRGESP [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "seeded onto coated soluble A1-40."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0439509:/40 [Temporal Concept]
   753   C1522408:Coated [Qualitative Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719   C0036563:Seed [Plant]
   719 E C0453946:Coat [Manufactured Object]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.129: After a 60-min incubation at 37C, attached cells were quantitated. 

Phrase: "After a 60-min incubation"

Phrase: "at 37C,"

Phrase: "attached cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "quantitated."
Processing 00000000.tx.130: Values represent the meanSD; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.131: n =9. 

Phrase: "n =9."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.132: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.134: FACS analysis of 51 integrin expression on IMR-32 neuroblastoma cells and CHO cells. 

Phrase: "FACS analysis of 51 integrin expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "on IMR-32 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: 51 surface expression by three IMR-32 cell clones transfected with human 5 cDNA. 

Phrase: "51 surface expression by three IMR-32 cell clones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0699040:Cell surface [Cell Component]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205148:Surface [Spatial Concept]

Phrase: "transfected with human 5 cDNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086418:Human [Human]
Processing 00000000.tx.136: IMR-32/ 51 clone 4(A), IMR-32/ 51 clone 15(B), and IMR-32/51 clone 16(C; 

Phrase: "IMR-32/ 51 clone 4"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0009013:Clone [Cell]
   804   C1522642:Clone [Tissue]
   733 E C1704387:Clonal [Qualitative Concept]
   704 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "IMR-32/ 51 clone 15"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0009013:Clone [Cell]
   804   C1522642:Clone [Tissue]
   733 E C1704387:Clonal [Qualitative Concept]
   704 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IMR-32/51 clone 16"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0009013:Clone [Cell]
   804   C1522642:Clone [Tissue]
   733 E C1704387:Clonal [Qualitative Concept]
   704 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(C"

Phrase: ";"
Processing 00000000.tx.137: solid lines) is compared with a vector-transfected control line IMR32/c (A and B; dashed lines), and the parental cell line IMR-32/p (C; dashed line). 

Phrase: "solid lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "compared with a vector-transfected control line IMR32/c (A"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   757   C0031249:control vector [Occupational Activity]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205132:Line [Spatial Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0442335:Vector [Spatial Concept]
   739   C1550141:Control [Substance]
   739   C1550648:Line [Substance]
   739   C1552960:Line [Quantitative Concept]
   739   C1705099:Vector [Idea or Concept]
   739   C1707455:Compared [Activity]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the parental cell line IMR-32/p (C"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0007600:Cell Line [Cell]
   818   C0851287:32-P [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0007634:Cell [Cell]
   795   C0030551:Parental [Family Group]
   795   C0205132:Line [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "; dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: (D) CHO cells transfected with the human 5 cDNA express 51 on their surface (solid line), whereas the vector-transfected control cells (CHO-B2/c) do not (dashed line). 

Phrase: "("

Phrase: "D)"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the human 5 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086418:Human [Human]

Phrase: "express"

Phrase: "51 on their surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205148:Surface [Spatial Concept]

Phrase: "(solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the vector-transfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0031249:vector control [Occupational Activity]
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(CHO-B2/c)"

Phrase: "do"

Phrase: "not (dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: Cells were stained with a monoclonal antibody to the human 5 integrin subunit, followed by an FITC-labeled secondary antibody, and analyzed by FACS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with a monoclonal antibody"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to the human 5 integrin subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "followed by an FITC-labeled secondary antibody,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C1719822:Follow [Intellectual Product]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "analyzed by FACS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.140: (E) CHO cells transfected with the human v cDNA express v1 on their surface (solid line), whereas the vector-transfected control cells (CHO-B2/c) do not. 

Phrase: "(E) CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the human v cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086418:Human [Human]

Phrase: "express"

Phrase: "v1 on their surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0457422:V1 [Finding]
   770   C0507238:V1 [Body Part, Organ, or Organ Component]

Phrase: "(solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the vector-transfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0031249:vector control [Occupational Activity]
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(CHO-B2/c)"

Phrase: "do"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.141: The staining was with a monoclonal antibody to the human v integrin subunit. 

Phrase: "The staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was with a monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0746619:monoclonal [Finding]
   760   C1421478:WAS [Gene or Genome]

Phrase: "to the human v integrin subunit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.142: We also tested the 5-negative human neuroblastoma cell line IMR-32 (Neill et al., 1994) for A attachment with (IMR-32/51+) and without (IMR-32/c) 5 transfection (Fig. 2 A). 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the 5-negative human neuroblastoma cell line IMR-32"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   842   C0682523:Human Cell Line [Cell]
   822   C0427861:human cell [Laboratory or Test Result]
   812   C0007600:Cell Line [Cell]
   812   C0815000:neuroblastoma cell [Cell]
   793   C0007634:Cell [Cell]
   793   C0027819:Neuroblastoma [Neoplastic Process]
   793   C0086418:Human [Human]
   793   C0205132:Line [Spatial Concept]
   793   C0205160:Negative [Qualitative Concept]
   793   C0439084:>5 [Quantitative Concept]
   793   C0700095:neuroblastoma [Neoplastic Process]
   793   C0728893:+5 [Quantitative Concept]
   793   C1269647:Cell [Cell]
   793   C1513916:Negative [Finding]
   793   C1550648:Line [Substance]
   793   C1552960:Line [Quantitative Concept]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C2825415:Negative [Conceptual Entity]
   793   C2825491:Negative [Qualitative Concept]
   793   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(Neill et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "for A attachment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Attachment [Therapeutic or Preventive Procedure]
  1000   C1947904:Attachment [Activity]
  1000   C1999228:Attachment [Intellectual Product]

Phrase: "with"

Phrase: "(IMR-32/51+"

Phrase: ")"

Phrase: "and without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(IMR-32/c) 5 transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(Fig. 2 A"

Phrase: ")."
Processing 00000000.tx.143: Three separate clones were obtained that expressed human 51 on their surface as detected by FACS analysis (Fig. 2, A-C). 

Phrase: "Three separate clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "that expressed human 51 on their surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086418:Human [Human]
   748   C0205148:Surface [Spatial Concept]

Phrase: "as"

Phrase: "detected by FACS analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C)."
Processing 00000000.tx.144: Each 51-expressing clone adhered to coated A1-40 in a dose-dependent manner (Fig. 3 A), and cell adhesion was inhibitable by an anti-5 antibody (data not shown). 

Phrase: "Each 51-expressing clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "adhered to coated A1-40"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0231441:Adhered [Finding]
   760   C0439509:/40 [Temporal Concept]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(Fig. 3 A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "inhibitable by an anti-5 antibody"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.145: The control-transfected IMR-32 cells (Fig. 2, A-C) attached poorly to this substrate (Fig. 3 A). 

Phrase: "The control-transfected IMR-32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C)"

Phrase: "attached"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231441:Attached [Finding]
   966 E C1314972:ATTACH [Intellectual Product]

Phrase: "poorly to this substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205169:Poorly [Qualitative Concept]
   770   C1710236:Substrate [Manufactured Object]

Phrase: "(Fig. 3 A"

Phrase: ")."
Processing 00000000.tx.146: Both the transfected and control cells attached well to vitronectin (data not shown), whereas the control peptide A40-1 and fibrillar A1-40 did not promote adhesion above BSA background levels for any of the IMR-32 cell lines (Fig. 3 B). 

Phrase: "Both"

Phrase: "the transfected"

Phrase: "and"

Phrase: "control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "attached"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231441:Attached [Finding]
   966 E C1314972:ATTACH [Intellectual Product]

Phrase: "well to vitronectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205170:Well [Qualitative Concept]
   790   C1336937:VITRONECTIN [Gene or Genome]
   790   C3146287:Well [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the control peptide A40-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "fibrillar A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "adhesion above BSA background levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "for any"

Phrase: "of the IMR-32 cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 3 B"

Phrase: ")."
Processing 00000000.tx.147: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.149: Adhesion of IMR-32 cells to coated A. 

Phrase: "Adhesion of IMR-32 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007577:Cell Adhesion [Cell Function]
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to coated A."
Processing 00000000.tx.150: (A) Adhesion of IMR-32 cells transfected with the human 5 subunit IMR-32/ 51 and vector-transfected IMR-32/c cells to A1-40 was measured as described in the legend for Fig. 

Phrase: "(A) Adhesion of IMR-32 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "transfected with the human 5 subunit IMR-32/ 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0086418:Human [Human]
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "vector-transfected IMR-32/c cells to A1-40"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   731   C0229579:C-Cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.151: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.152: (B) IMR-32 cell transfectants and control IMR-32/c and IMR-32/p cells were plated on A1-40 coated in its soluble or fibrillar form or on the control peptide A40-1, and cell adhesion was measured as described in the legend for Fig. 

Phrase: "(B) IMR-32 cell transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "control IMR-32/c"

Phrase: "and"

Phrase: "IMR-32/p cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0851287:32-P [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C1179870:P cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on A1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439509:/40 [Temporal Concept]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "coated in its soluble"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1522408:Coated [Qualitative Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "fibrillar form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "or on the control peptide A40-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.153: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.154: Values in A and B represent the meanSD; 

Phrase: "Values in A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.155: n =9. 

Phrase: "n =9."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.156: 51 Reduces the Formation of an Insoluble A Fibrillar Extracellular Matrix An increase of insoluble A fibrillar matrix is one hallmark of AD (Glenner and Wong, 1984; Masters et al., 1985). 

Phrase: "51"

Phrase: "Reduces"

Phrase: "the Formation of an Insoluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "A Fibrillar Extracellular Matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0015350:Extracellular Matrix [Tissue]
   827   C0521119:Extracellular [Cell Component]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "An increase of insoluble"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "A fibrillar matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "one hallmark of AD (Glenner"

Phrase: "and"

Phrase: "Wong,"

Phrase: "1984"

Phrase: "; Masters et al.,"

Phrase: "1985"

Phrase: ")."
Processing 00000000.tx.157: As shown above, the 51 integrin bound to coated A with the highest avidity among the integrins we tested. 

Phrase: "As"

Phrase: "shown above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "the 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "bound to coated A"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1522408:Coated [Qualitative Concept]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "with the highest avidity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1510996:Avidity [Qualitative Concept]
   789 E C2986972:Avid [Organic Chemical,Pharmacologic Substance]

Phrase: "among the integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "we"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.158: Therefore, we asked whether 51 would affect the formation of an A fibrillar matrix. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "51"

Phrase: "would"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the formation of an"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "A fibrillar matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.159: Exogenous A1-40 added to cell cultures formed a matrix around the cells that was detectable by immunostaining with anti-A antibodies. 

Phrase: "Exogenous A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205101:Exogenous [Spatial Concept]
   827   C0205228:Exogenous [Functional Concept]
   827   C0439509:/40 [Temporal Concept]

Phrase: "added to cell cultures"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0007585:Cell Cultures [Laboratory Procedure]
   770   C0007634:Cell [Cell]
   770   C0010453:Cultures [Idea or Concept]
   770   C1269647:Cell [Cell]
   770   C1524062:Added [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a matrix around the cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1383501:Cell Matrix [Cell Component]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "that"

Phrase: "was"

Phrase: "detectable by immunostaining"

Phrase: "with anti-A antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.160: There was a substantial decrease in the formation of matrix from added A in cultures of the 51-expressing IMR-32 cell lines compared with the control lines (Fig. 4, A-D). 

Phrase: "There"

Phrase: "was"

Phrase: "a substantial decrease in the formation of matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "from added A"

Phrase: "in cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "of the 51-expressing IMR-32 cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0007600:Cell lines [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "compared with the control lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205132:lines [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-D)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.161: Moreover, the matrix in the 51+ cell cultures appeared to be cell-associated, whereas in the 51 cell cultures it appeared to be largely independent of the cells. 

Phrase: "Moreover,"

Phrase: "the matrix in the 51+ cell cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1383501:Cell Matrix [Cell Component]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cell-associated,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0699040:cell associated [Cell Component]
   861   C0332281:Associated [Qualitative Concept]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]

Phrase: "whereas in the 51 cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0007585:Cell Cultures [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Cultures [Idea or Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "it"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely independent of the cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0332291:Independent of [Functional Concept]
   760   C0007634:Cells [Cell]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: View larger version (181K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(181K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 4.  

Phrase: "4."
Processing 00000000.tx.164: Immunofluorescent detection of reduced A matrix in cultures expressing the 51 integrin. 

Phrase: "Immunofluorescent detection of reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "A matrix in cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]

Phrase: "expressing"

Phrase: "the 51 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.165: Deposition of A1-40 matrix from soluble A added to the culture media of IMR-32 control cells IMR-32/c (A) and IMR-32/p (B), and of 51 expressing IMR-32 clones 4(C) and 15(D) was examined. 

Phrase: "Deposition of A1-40 matrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "from soluble A"

Phrase: "added to the culture media"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C1524062:Added [Functional Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C1883712:Add [Functional Concept]
   726 E C3244283:medium [Intellectual Product]

Phrase: "of IMR-32 control cells IMR-32/c (A)"

Phrase: "and"

Phrase: "IMR-32/p (B"

Phrase: ")"

Phrase: ","

Phrase: "and of 51 expressing IMR-32 clones 4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0009013:Clones [Cell]
   744   C1515981:And [Idea or Concept]
   711 E C1522642:Clone [Tissue]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "15"

Phrase: "("

Phrase: "D)"

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.166: The A matrix was detected by a polyclonal anti-A1-40 antibody followed by a rhodamine-labeled secondary antibody. 

Phrase: "The"

Phrase: "A matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "was"

Phrase: "detected by a polyclonal anti-A1-40 antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0432617:Anti-A1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368589:A1 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0439509:/40 [Temporal Concept]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "followed by a rhodamine-labeled secondary antibody."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C1719822:Follow [Intellectual Product]
   714 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.167: The experiment was repeated at least three times for each cell line, and representative results are shown. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "for each cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: Bar, 50m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "50m."
Processing 00000000.tx.169: To study quantitatively the formation of the A matrix, the various IMR-32 lines were incubated with 125I-labeled A for 72h, and the amount of radiolabeled A that had become soluble in detergent was measured. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "quantitatively"

Phrase: "the formation of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "A matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "the various IMR-32 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "A for 72h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292423:72H [Temporal Concept]

Phrase: "and"

Phrase: "the amount of radiolabeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "A that"

Phrase: "had"

Phrase: "become"

Phrase: "soluble in detergent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1749467:soluble [Cell Component]
   790   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.170: The IMR-32 clones expressing 51 deposited fivefold less insoluble A radioactivity than the control cells. 

Phrase: "The IMR-32 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "51 deposited fivefold less insoluble"

Phrase: "A radioactivity than the control cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0034553:Radioactivity [Natural Phenomenon or Process]
Processing 00000000.tx.171: Moreover, the P1D6 anti-5 antibody returned A matrix formation in the 51-expressing IMR-32 cultures to the level in the parental control cells (Fig. 5 A). 

Phrase: "Moreover,"

Phrase: "the P1D6 anti-5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "A matrix formation in the 51-expressing IMR-32 cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "to the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "in the parental control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0814584:parental control [Social Behavior]
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.172: A control antibody had no effect. 

Phrase: "A control antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.173: CHO cells expressing 51 also had less A matrix than their control-transfected counterpart cells as judged from the insolubility of [125I]A; 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "51 also"

Phrase: "had"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "A matrix than their control-transfected counterpart cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C1383501:Cell Matrix [Cell Component]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]

Phrase: "as"

Phrase: "judged from the insolubility of [125I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0221191:Judge [Professional or Occupational Group]

Phrase: "]A"

Phrase: ";"
Processing 00000000.tx.174: the difference was fourfold (Fig. 5 B). 

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "fourfold"

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.175: Adding the anti-5 antibody canceled the 51 effect, but a control antibody did not. 

Phrase: "Adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "the anti-5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "canceled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Canceled [Qualitative Concept]

Phrase: "the 51 effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "a control antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.176: The insolubility of A remained the same in the CHO control cell cultures regardless of the antibody added. 

Phrase: "The insolubility of A remained"

Phrase: "the same in the CHO control cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0445247:Same [Qualitative Concept]

Phrase: "cultures regardless of the antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0010453:Culture [Idea or Concept]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3641650:Regardless [Qualitative Concept]

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.177: These results indicate that cell expression of 51 reduces A matrix deposition threefold relative to the control cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that cell expression of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reduces"

Phrase: "A matrix deposition threefold relative to the control cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.178: Because iodinated A forms fibrils less readily than unlabeled A1-40 (Bush et al., 1994), it was not possible to use the [125I]A to quantitate the proportion of the added A1-40 that becomes insolubilized. 

Phrase: "Because"

Phrase: "iodinated"

Phrase: "A forms fibrils less readily than unlabeled A1-40"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0225328:fibrils [Cell Component]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C0439509:/40 [Temporal Concept]
   708 E C1522492:Form [Functional Concept]
   708 E C1948066:Fibril [Physical Object]

Phrase: "(Bush et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the [125I"

Phrase: "]"

Phrase: "A to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "the proportion of the added A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709707:Proportion [Quantitative Concept]

Phrase: "that"

Phrase: "becomes"

Phrase: "insolubilized."
Processing 00000000.tx.179: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.181: Quantitation of A matrix deposition in cultures of IMR-32 cells and their 51-expressing clones. 

Phrase: "Quantitation of A matrix deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "in cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "of IMR-32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their 51-expressing clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.182: (A) 125I-labeled soluble A1-40 was incubated with cultures of two control lines and three 51-expressing lines at 37C for 72h in the presence of either the monoclonal antibody to the human 5 integrin subunit (P1D6) or control IgG. 

Phrase: "(A) 125I-labeled soluble A1-40"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439509:/40 [Temporal Concept]
   799   C1708632:Labeled [Qualitative Concept]
   799   C1749467:soluble [Cell Component]
   799   C1948047:Soluble [Qualitative Concept]
   766 E C0181496:Label [Manufactured Object]
   766 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "incubated with cultures of two control lines"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   748   C0010453:Cultures [Idea or Concept]
   748   C0205132:lines [Spatial Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]
   714 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "three 51-expressing lines at 37C"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "for 72h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292423:72H [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of either"

Phrase: "the monoclonal antibody to the human 5 integrin subunit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0746619:monoclonal [Finding]

Phrase: "(P1D6"

Phrase: ")"

Phrase: "or"

Phrase: "control IgG."
Processing 00000000.tx.183: The total amount of 125I-labeled A1-40 associated with an SDS soluble matrix was determined as described in Materials and Methods. 

Phrase: "The total amount of 125I-labeled A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "associated with an SDS soluble matrix"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.184: The reduction of A1-40 matrix deposition in the 51-expressing cultures was reversed by an anti-5 integrin monoclonal antibody (P1D6), but not by the control IgG. 

Phrase: "The reduction of A1-40 matrix deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the 51-expressing cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "reversed by an anti-5 integrin monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0746619:monoclonal [Finding]
   711   C1555029:Reverse [Idea or Concept]

Phrase: "(P1D6"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by the control IgG."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.185: (B) CHO-B2/51 cells show reduced deposition of [125I] to A matrix relative to control CHO cells. 

Phrase: "(B) CHO-B2/51 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0004561:B-Cells [Cell]
   875   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reduced deposition of [125I"

Phrase: "]"

Phrase: "to A matrix relative to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: The experimental procedure was the same as in A. 

Phrase: "The experimental procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as in A."
Processing 00000000.tx.187: The P1D6 antibody reversed the 51-dependent matrix reduction, whereas the control mouse IgG had no effect. 

Phrase: "The P1D6 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the 51-dependent matrix reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0301630:Reduction [Natural Phenomenon or Process]
   812   C0392756:Reduction [Qualitative Concept]
   812   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "the control mouse IgG"

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.188: Experiments in A and B were repeated at least four times, and representative results are shown. 

Phrase: "Experiments in A"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "repeated at least four times,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.189: Values represent the meanSD; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.190: n =3. 

Phrase: "n =3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.191: Soluble A1-40 is Taken Up By Cells and Partially Degraded Via an 51-Mediated Pathway Possible reasons for the 51-mediated reduction of A matrix include internalization of soluble A1-40, degradation of the peptide, or both. 

Phrase: "Soluble A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439509:/40 [Temporal Concept]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "is"

Phrase: "Taken Up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "By Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Partially"

Phrase: "Degraded Via an 51-Mediated Pathway Possible reasons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0332149:Possible [Qualitative Concept]
   744   C0392360:reasons [Idea or Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705910:Possible [Qualitative Concept]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1881707:DEGRADED [Phenomenon or Process]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "for the 51-mediated reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0301630:Reduction [Natural Phenomenon or Process]
   827   C0392756:Reduction [Qualitative Concept]
   827   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of A matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "internalization of soluble A1-40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "degradation of the peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1523817:peptide degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.192: Neuronal cells have been shown to internalize A, but the mechanism for this internalization is only incompletely known (Ida et al., 1996, Hammad et al., 1997). 

Phrase: "Neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "internalize"

Phrase: "A,"

Phrase: "but"

Phrase: "the mechanism for this internalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "only incompletely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "(Ida et al.,"

Phrase: "1996,"

Phrase: "Hammad et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.193: To investigate the possibility that binding 51 to soluble A initiates cellular uptake of A, we examined the processing of 125I-labeled A1-40 by 51+ and 51 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that binding 51 to soluble A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "cellular uptake of A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the processing of 125I-labeled A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709694:Processing [Activity]

Phrase: "by 51+"

Phrase: "and"

Phrase: "51 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.194: Initially, CHO-B2/c control cells and transfectants were incubated for 1h with [125I]A1-40, and were then examined for cell-associated radioactivity. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "CHO-B2/c control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   897   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transfectants"

Phrase: "were"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "with"

Phrase: "[125I"

Phrase: "]A1-40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined for cell-associated radioactivity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0034553:Radioactivity [Natural Phenomenon or Process]
   760   C0332128:Examined [Finding]
   760   C0332281:Associated [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.195: The 51-expressing CHO-B2 cells contained twofold more radioactivity at 1and 12h than the control CHO-B2/c cells (Fig. 6 A). 

Phrase: "The 51-expressing CHO-B2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "twofold more radioactivity at 1and 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "than the control CHO-B2/c cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   875   C0085080:CHO Cells [Cell]
   806   C0229579:C-Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6 A"

Phrase: ")."
Processing 00000000.tx.196: View larger version (16K): [in this window] [in a new window]  View larger version (25K): [in this window] [in a new window]  View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.197: 6.  

Phrase: "6."
Processing 00000000.tx.198: 51-expressing cells take up and degrade soluble A. 

Phrase: "51-expressing cells take up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "degrade"

Phrase: "soluble A."
Processing 00000000.tx.199: (A) Cell-associated 125I-labeled A1-40 in CHO-B2/c control cells and 51-expressing CHO-B2 cells. 

Phrase: "(A) Cell-associated 125I-labeled A1-40"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   818   C0699040:cell associated [Cell Component]
   795   C0007634:Cell [Cell]
   795   C0332281:Associated [Qualitative Concept]
   795   C0439509:/40 [Temporal Concept]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1708632:Labeled [Qualitative Concept]
   795   C1948049:Cell [Spatial Concept]
   762 E C0181496:Label [Manufactured Object]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]
   762 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in CHO-B2/c control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   897   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "51-expressing CHO-B2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.200: Cell cultures were incubated for 1h with soluble 125I-labeled A1-40, detached with EDTA, and solubilized with NP40 representing both cell-associated and internalized A. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "with soluble 125I-labeled A1-40,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0439509:/40 [Temporal Concept]
   804   C1708632:Labeled [Qualitative Concept]
   804   C1749467:soluble [Cell Component]
   804   C1948047:Soluble [Qualitative Concept]
   771 E C0181496:Label [Manufactured Object]
   771 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "detached with EDTA,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]
   718 E C0541879:detachment [Mental Process]
   718 E C0595950:Detachment [Pathologic Function]

Phrase: "and"

Phrase: "solubilized with NP40 representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1882932:Represent [Activity]

Phrase: "both cell-associated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0699040:cell associated [Cell Component]
   861   C0332281:Associated [Qualitative Concept]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "internalized"

Phrase: "A."
Processing 00000000.tx.201: (B) Degradation of 125I-labeled A1-40 in IMR-32 control cells and 51-expressing clones. 

Phrase: "(B) Degradation of 125I-labeled A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "in IMR-32 control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "51-expressing clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.202: The cultures were incubated with soluble 125I-labeled A1-40 over a 72-h period, and cells were detached with EDTA, solubilized with NP40, and the NP40 extracts were precipitated with trichloroacetic acid (TCA) to separate 125I-labeled A into a degraded soluble fraction and an insoluble fraction representing intact or partially degraded A. 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated with soluble 125I-labeled A1-40"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0439509:/40 [Temporal Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1708632:Labeled [Qualitative Concept]
   748   C1749467:soluble [Cell Component]
   748   C1948047:Soluble [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "over a 72-h period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detached with EDTA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]

Phrase: "solubilized with NP40,"

Phrase: "and"

Phrase: "the NP40 extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "precipitated with trichloroacetic acid (TCA) to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "125I-"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "A into a degraded soluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1749467:soluble [Cell Component]
   753   C1881707:DEGRADED [Phenomenon or Process]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "an insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "or"

Phrase: "partially"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.203: (C) Cell-associated 125I-labeled A1-40 in CHO control cells (CHO-B2/c) and 51-expressing clones (CHO-B2/51). 

Phrase: "(C) Cell-associated 125I-labeled A1-40"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   818   C0229579:C-Cell [Cell]
   818   C0699040:cell associated [Cell Component]
   795   C0007634:Cell [Cell]
   795   C0332281:Associated [Qualitative Concept]
   795   C0439509:/40 [Temporal Concept]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1708632:Labeled [Qualitative Concept]
   795   C1948049:Cell [Spatial Concept]
   762 E C0181496:Label [Manufactured Object]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]
   762 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in CHO control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(CHO-B2/c)"

Phrase: "and"

Phrase: "51-expressing clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(CHO-B2/51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0507114:B2 [Body Part, Organ, or Organ Component]
   827   C1416271:B2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.204: (D and E) Release of [125I] from 125I-labeled A1-40 into cell culture medium. 

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E)"

Phrase: "Release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of [125I"

Phrase: "]"

Phrase: "from 125I-labeled A1-40"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0439509:/40 [Temporal Concept]
   812   C1708632:Labeled [Qualitative Concept]
   779 E C0181496:Label [Manufactured Object]
   779 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "into cell culture medium."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0007634:Cell [Cell]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705217:Medium [Substance]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]
Processing 00000000.tx.205: 125I-labeled soluble A1-40 was added to the culture media of various IMR-32 (D) or CHO (E) cell lines and incubated for 1h. 

Phrase: "125I-labeled soluble A1-40"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0439509:/40 [Temporal Concept]
   804   C1708632:Labeled [Qualitative Concept]
   804   C1749467:soluble [Cell Component]
   804   C1948047:Soluble [Qualitative Concept]
   771 E C0181496:Label [Manufactured Object]
   771 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "added to the culture media of various IMR-32"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   742   C0009458:Media [Intellectual Product]
   742   C0010453:Culture [Idea or Concept]
   742   C0162867:Media [Tissue]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   742   C1254021:Media [Tissue]
   742   C1524062:Added [Functional Concept]
   742   C2242979:Culture [Laboratory Procedure]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1705217:Medium [Substance]
   708 E C1883712:Add [Functional Concept]
   708 E C3244283:medium [Intellectual Product]

Phrase: "("

Phrase: "D)"

Phrase: "or"

Phrase: "CHO (E) cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C0085080:CHO cell [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "incubated for 1h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]
Processing 00000000.tx.206: After that, the media was removed, the cell layer was washed, and new media was added. 

Phrase: "After"

Phrase: "that,"

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "the cell layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "new media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0870959:new media [Human-caused Phenomenon or Process]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.207: The release of radioactivity into the media was monitored over a 72-h period. 

Phrase: "The release of radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "monitored over a 72-h period."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439531:/period [Temporal Concept]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1948053:Period [Temporal Concept]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.208: Experiments in A-E were repeated at least three times, and representative results are shown. 

Phrase: "Experiments in A-E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "repeated at least three times,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.209: Values in A-E represent the meanSD; 

Phrase: "Values in A-E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.210: n =3. 

Phrase: "n =3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.211: Cell cultures were then incubated with 125I-labeled A over a 72-h period to determine whether the [125I]A taken up by the cells was degraded. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "A over"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]

Phrase: "a 72-h period to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the [125I"

Phrase: "]"

Phrase: "A"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.212: 51-expressing IMR-32 cells contained twofold more radioactivity after the 72-h incubation than 51-negative IMR-32 cells (Fig. 6 B). 

Phrase: "51-expressing IMR-32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "twofold more radioactivity after the 72-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "than 51-negative IMR-32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6 B"

Phrase: ")."
Processing 00000000.tx.213: Part of the radioactivity was soluble in TCA, indicating that A had been degraded. 

Phrase: "Part of the radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "was"

Phrase: "soluble in TCA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "A"

Phrase: "had"

Phrase: "been"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.214: CHO cells internalized and degraded soluble A in a similar manner, with 51-expressing cells containing eightfold more TCA-soluble radioactivity than 51-negative cells (Fig. 6 C). 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "internalized"

Phrase: "and"

Phrase: "degraded soluble A in a similar manner,"

Phrase: "with 51-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "eightfold more TCA-soluble radioactivity than 51-negative cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(Fig. 6 C)."
Processing 00000000.tx.215: The CHO cells expressing 51 bound 10% of the added A, whereas the control cells bound only 0.4%. 

Phrase: "The CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "51"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "10% of the added A,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "whereas"

Phrase: "the control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "only 0.4%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]
Processing 00000000.tx.216: Moreover, 90% of the cell-associated A was degraded in the CHO-51 expressers. 

Phrase: "Moreover,"

Phrase: "90% of the cell-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A"

Phrase: "was"

Phrase: "degraded in the CHO-51 expressers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.217: The higher expression levels of 51 on the CHO transfectants (Fig. 2, D and E) may explain why these cells bound and internalized more radiolabeled A than the IMR-32 transfectants. 

Phrase: "The higher expression levels of 51"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "on the CHO transfectants"

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E)"

Phrase: "may"

Phrase: "explain"

Phrase: "why"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "internalized"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A than the IMR-32 transfectants."
Processing 00000000.tx.218: We next examined whether A was released into the culture medium. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "A"

Phrase: "was"

Phrase: "released into the culture medium."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0391871:Released [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1283071:Released [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.219: The release of radioactivity into cell culture media was monitored over a 72-h period that followed a 1-h incubation with 125I-labeled A1-40. 

Phrase: "The release of radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into cell culture media"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007634:Cell [Cell]
   827   C0009458:Media [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0162867:Media [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1254021:Media [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "monitored over a 72-h period"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439531:/period [Temporal Concept]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1948053:Period [Temporal Concept]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]

Phrase: "that"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 1-h incubation with 125I-labeled A1-40."
Processing 00000000.tx.220: The media of 51-expressing IMR-32 and CHO cells contained twofold more radioactivity than the corresponding control cell media (Fig. 6, D and E). 

Phrase: "The media of 51-expressing IMR-32"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0009458:Media [Intellectual Product]
   748   C0162867:Media [Tissue]
   748   C1254021:Media [Tissue]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "twofold more radioactivity than the corresponding control cell media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.221: These results point to an 51-dependent pathway that internalizes and degrades A. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "point to an 51-dependent pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1552961:Point [Quantitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2347617:point [Quantitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "that"

Phrase: "internalizes"

Phrase: "and"

Phrase: "degrades"

Phrase: "A."
Processing 00000000.tx.222: 51 Protects Cells Against A Induced Apoptosis Having established an 51-dependent mechanism for the inhibition of A matrix deposition, we examined whether the reduction of the A matrix would promote neuronal cell survival in cultures treated with A. 

Phrase: "51"

Phrase: "Protects"

Phrase: "Cells Against A Induced Apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "Having"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "an 51-dependent mechanism for the inhibition of A matrix deposition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the reduction of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "A matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "would"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neuronal cell survival in cultures"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007620:Cell Survival [Cell Function]
   797   C0007585:Cell Cultures [Laboratory Procedure]
   762   C1819944:neuron survival [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "treated with A."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.223: IMR-32 cell lines cultured with exogenous soluble A1-40 underwent apoptosis in the absence of 51 (Fig. 7, A and B), but three 51-expressing lines did not (two are shown in Fig. 7, C and D). 

Phrase: "IMR-32 cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "cultured with exogenous soluble A1-40"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205101:Exogenous [Spatial Concept]
   753   C0205228:Exogenous [Functional Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "underwent"

Phrase: "apoptosis in the absence of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "three 51-expressing lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "did"

Phrase: "not (two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "shown in Fig. 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.224: The control peptide A40-1 caused no apoptosis in the control (Fig. 7, E and F) or 51-expressing cells (not shown). 

Phrase: "The control peptide A40-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "no apoptosis in the control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E"

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or"

Phrase: "51-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: Analysis of acridine orange/ethidium bromide uptake revealed three times more apoptosis in the control cells than in the IMR-32 51-expressers (Fig. 8). 

Phrase: "Analysis of acridine orange/ethidium bromide uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "three times more apoptosis in the control cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "than"

Phrase: "in the IMR-32 51-expressers"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.227: 7.  

Phrase: "7."
Processing 00000000.tx.228: Effect of A matrix on apoptosis. 

Phrase: "Effect of A matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.229: Expression of 51 protects IMR-32 neuroblastoma cells from apoptosis induced by A matrix formation. 

Phrase: "Expression of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "protects"

Phrase: "IMR-32 neuroblastoma cells from apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "induced by A matrix formation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205263:Induced [Functional Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.230: Cell cultures were incubated for 72h with A1-40 to allow aggregation of A into a matrix, and the cultures were then examined for evidence of cytotoxicity by using the TUNEL assay. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with A1-40 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregation of A into a matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined for evidence of cytotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
   760   C0332128:Examined [Finding]
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TUNEL assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1515232:TUNEL Assay [Molecular Biology Research Technique]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0600528:TUNEL [Molecular Biology Research Technique]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.231: A percentage of IMR-32/c (A) and IMR-32/p (B) cells underwent apoptosis (green). 

Phrase: "A percentage of IMR-32/c (A)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "and"

Phrase: "IMR-32/p (B) cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "underwent"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.232: The viable cells (red) are counterstained with propidium iodide. 

Phrase: "The viable cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1441322:Viable cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "are"

Phrase: "counterstained with propidium iodide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0021966:Iodide [Inorganic Chemical]
   770   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.233: No apoptotic cells were seen in IMR-32/51 transfectant clones 4(C) and 15(D) under the same conditions. 

Phrase: "No apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seen in IMR-32/51 transfectant clones 4"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0009013:Clones [Cell]
   744   C0205397:Seen [Qualitative Concept]
   711 E C0042789:see [Organism Function]
   711 E C1522642:Clone [Tissue]
   711 E C1947903:See [Activity]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "15"

Phrase: "("

Phrase: "D) under the same conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0445247:Same [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.234: (E-F) The IMR-32/c and IMR-32/p control cells remained viable when incubated for 72h with the inactive control peptide A40-1. 

Phrase: "(E-F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "The IMR-32/c"

Phrase: "and"

Phrase: "IMR-32/p control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "remained"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "when"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with the inactive control peptide A40-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C0205254:Inactive [Qualitative Concept]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.235: These experiments were repeated at least three times for each cell line, and representative results are shown. 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "repeated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "for each cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.236: Bar, 50m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "50m."
Processing 00000000.tx.237: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.238: 8.  

Phrase: "8."
Processing 00000000.tx.239: Effect of A matrix on apoptosis. 

Phrase: "Effect of A matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.240: Expression of 51 protects IMR-32 neuroblastoma cells from apoptosis induced by A matrix formation. 

Phrase: "Expression of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "protects"

Phrase: "IMR-32 neuroblastoma cells from apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "induced by A matrix formation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205263:Induced [Functional Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.241: Cell cultures were incubated for 72h with A1-40 to allow aggregation of A into a matrix, and the cultures were then examined for evidence of apoptosis by measuring the ability of cells to take up acridine orange/ethidium bromide. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with A1-40 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregation of A into a matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined for evidence of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
   760   C0162638:Apoptosis [Cell Function]
   760   C0332128:Examined [Finding]

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the ability of cells to take up acridine orange/ethidium bromide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0085732:Ability [Organism Attribute]
Processing 00000000.tx.242: A higher percentage of 51IMR-32/c and IMR-32/p cells than 51+ transfectants underwent apoptosis. 

Phrase: "A higher percentage of 51IMR-32/c"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "and"

Phrase: "IMR-32/p cells than 51+ transfectants"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0851287:32-P [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   745   C1179870:P cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "underwent"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.243: Values represent the meanSD; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.244: n =9. 

Phrase: "n =9."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.245: We also assessed the A effect by using the MTT assay, which measures cell viability by detecting the ability of a mitochondrial enzyme to reduce its substrate. 

Phrase: "We also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the A effect by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "which"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "cell viability by detecting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0007620:Cell Viability [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0443348:viability [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "the ability of a mitochondrial enzyme to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "reduce"

Phrase: "its substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.246: A-treated IMR-32 control cells lost their ability to reduce MTT in a manner that was dependent on the dose of A, whereas A had almost no effect on the 51-expressing cell lines (Fig. 9 A). 

Phrase: "A-treated IMR-32 control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   799   C0007634:Cells [Cell]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "MTT in a manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0647210:mtt [Lipid]

Phrase: "that"

Phrase: "was"

Phrase: "dependent on the dose of A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1512045:Dose-dependent [Quantitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "whereas"

Phrase: "A"

Phrase: "had"

Phrase: "almost"

Phrase: "no effect on the 51-expressing cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 9 A"

Phrase: ")."
Processing 00000000.tx.247: The control peptide A40-1 had no effect on MTT reduction in any of the cell types, even at the highest test concentration (Fig. 9 B). 

Phrase: "The control peptide A40-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on MTT reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in any"

Phrase: "of the cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "even at the highest test concentration"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0086045:Concentration [Mental Process]
   753   C0392366:test [Intellectual Product]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1522410:Highest [Qualitative Concept]
   719 E C0205250:High [Qualitative Concept]
   719 E C1299351:High [Qualitative Concept]
   719 E C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 9 B"

Phrase: ")."
Processing 00000000.tx.248: To examine further the cytotoxicity of A1-40, we used an assay that measures the release of LDH upon cell lysis (Behl et al., 1994). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the cytotoxicity of A1-40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "that"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the release of LDH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "upon cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "(Behl et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.249: A threefold increase in LDH levels relative to controls was seen in the 51 IMR-32 cells cultured in the presence of A1-40, whereas A1-40 had no effect on the LDH levels of the 51+ cells (Fig. 10 A). 

Phrase: "A threefold increase in LDH levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "relative to controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "seen in the 51 IMR-32 cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   748   C0007634:Cells [Cell]
   748   C0205397:Seen [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C0042789:see [Organism Function]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1947903:See [Activity]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in the presence of A1-40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439509:/40 [Temporal Concept]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "whereas"

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "had"

Phrase: "no effect on the LDH levels of the 51+ cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1301751:No effect [Qualitative Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 10 A"

Phrase: ")."
Processing 00000000.tx.250: These results indicate that 51-mediated A binding protects the IMR-32 cells from the cytotoxicity of aggregated A, presumably by inhibiting its aggregation into fibrils. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that 51-"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "protects"

Phrase: "the IMR-32 cells from the cytotoxicity of aggregated A,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   741   C0007634:THE CELL [Cell]
           Cells
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   705   C0022686:Cytotoxic cell [Cell]

Phrase: "presumably by inhibiting"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C3463820:Inhibiting [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "its aggregation into fibrils."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.251: No apoptosis was caused by A in any of the CHO cell lines, as examined by TUNEL staining, the MTT assay, and the LDH assay, indicating that these cells are resistant to the cytotoxic effects of an A matrix. 

Phrase: "No apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "caused by A in any of the CHO cell lines,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0007600:Cell lines [Cell]
   760   C0085080:CHO cell [Cell]
   739   C0007634:Cell [Cell]
   739   C0205132:lines [Spatial Concept]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706   C0015127:cause [Functional Concept]
   706   C1524003:Cause [Conceptual Entity]
   706 E C1550648:Line [Substance]
   706 E C1552960:Line [Quantitative Concept]

Phrase: "as"

Phrase: "examined by TUNEL staining,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332128:Examined [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   770   C1704680:Staining [Finding]

Phrase: "the MTT assay,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "the LDH assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "indicating"

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "resistant to the cytotoxic effects of an"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "A matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]
Processing 00000000.tx.252: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.253: 9.  

Phrase: "9."
Processing 00000000.tx.254: Effect of A1-40 on cell viability. 

Phrase: "Effect of A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.255: Cell survival in cultures containing aggregated A. 

Phrase: "Cell survival in cultures"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007620:Cell Survival [Cell Function]
   819   C0007585:Cell Cultures [Laboratory Procedure]
   770   C0007634:Cell [Cell]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.256: Cell cultures were incubated for 72h with A1-40 to allow aggregation of A into a matrix, and the cultures were then examined for their ability to reduce MTT. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with A1-40 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregation of A into a matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0332128:Examined [Finding]

Phrase: "reduce"

Phrase: "MTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]
Processing 00000000.tx.257: (A) The control cellsIMR-32/c (circles) and IMR-32/p (triangles)lost the ability to reduce MTT, whereas the IMR-32/51 clones 4(diamonds) and 15(squares) were essentially resistant under the same conditions. 

Phrase: "(A)"

Phrase: "The control cellsIMR-32/c (circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1282913:Circle [Spatial Concept]
   771   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "IMR-32/p (triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "whereas"

Phrase: "the IMR-32/51 clones 4"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "(diamonds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0057717:Diamonds [Element, Ion, or Isotope]
   966 E C1706341:Diamond [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "15"

Phrase: "(squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "essentially resistant under the same conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332325:Resistant [Functional Concept]
   753   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.258: Values represent the meanSD; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.259: n =9.(B) The control peptide A40-1 did not affect the ability of any cell type to reduce MTT. 

Phrase: "n =9."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The control peptide A40-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of any cell type to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "reduce"

Phrase: "MTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]
Processing 00000000.tx.260: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.261: 10.  

Phrase: "10."
Processing 00000000.tx.262: Cell survival in cultures containing aggregated A. 

Phrase: "Cell survival in cultures"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007620:Cell Survival [Cell Function]
   819   C0007585:Cell Cultures [Laboratory Procedure]
   770   C0007634:Cell [Cell]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.263: Cell cultures were incubated for 72h with A1-40 to allow aggregation of A into a matrix, and the LDH levels within the cultures were analyzed. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for 72h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292423:72H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with A1-40 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregation of A into a matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "the LDH levels within the cultures"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   780   C0202113:Lactate dehydrogenase level [Laboratory Procedure]
   778   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0428445:lactate levels [Laboratory Procedure]
   774   C1304767:lactate levels [Laboratory or Test Result]
   748   C0022924:lactate [Organic Chemical]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.264: (A) The 51 cells IMR-32/c and IMR-32/p showed increased LDH levels, whereas the IMR-32/51 clones 4,15,and 16maintained LDH levels similar to those seen in the presence of the A40-1 control peptide. 

Phrase: "(A)"

Phrase: "The 51 cells IMR-32/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   897   C0049376:51 C [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "IMR-32/p"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0851287:32-P [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increased LDH levels,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0151754:Increased lactate dehydrogenase [Finding]
   890   C0202113:Lactate dehydrogenase level [Laboratory Procedure]
   875   C0428445:lactate levels [Laboratory Procedure]
   875   C1304767:lactate levels [Laboratory or Test Result]
   861   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0022924:lactate [Organic Chemical]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the IMR-32/51 clones 4,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "15,"

Phrase: "and"

Phrase: "16maintained LDH levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   890   C0202113:Lactate dehydrogenase level [Laboratory Procedure]
   875   C0428445:lactate levels [Laboratory Procedure]
   875   C1304767:lactate levels [Laboratory or Test Result]
   861   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0022924:lactate [Organic Chemical]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in the presence of the A40-1 control peptide."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0205397:Seen [Qualitative Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1550141:Control [Substance]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]
   706 E C0042789:see [Organism Function]
   706 E C1947903:See [Activity]
Processing 00000000.tx.265: Values represent the meanSD; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSD"

Phrase: ";"
Processing 00000000.tx.266: n =9.(B) Cell survival on A coated from freshly made solution onto a plastic surface. 

Phrase: "n =9."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B) Cell survival on A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "coated from freshly made solution"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726   C1881534:Make [Functional Concept]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "onto a plastic surface."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.267: Cells were seeded onto A1-40, fibronectin, and vitronectin coated onto microtiter wells, cultured in serum-free conditions, and examined by DAPI staining after 96h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded onto A1-40,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439509:/40 [Temporal Concept]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "coated onto microtiter wells,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1522408:Coated [Qualitative Concept]
   737   C0205170:Well [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3146287:Well [Manufactured Object]

Phrase: "cultured in serum-free conditions,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0220814:culture [Functional Concept]
   726   C0348080:Condition [Qualitative Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C1705253:Condition [Conceptual Entity]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "examined by DAPI staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332128:Examined [Finding]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "after 96h."
Processing 00000000.tx.268: The 51 transfectants remained viable on A1-40 and fibronectin, but not on vitronectin. 

Phrase: "The 51 transfectants"

Phrase: "remained"

Phrase: "viable on A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not on vitronectin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336937:VITRONECTIN [Gene or Genome]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.269: We previously demonstrated that cell attachment through 51 protects CHO cells from apoptosis when cultured in a serum-free environment (Zhang et al., 1995). 

Phrase: "We previously"

Phrase: "demonstrated"

Phrase: "that cell attachment through 51"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0887869:Cell Attachment [Cell Component]
   760   C0185023:Attachment [Therapeutic or Preventive Procedure]
   760   C1947904:Attachment [Activity]
   760   C1999228:Attachment [Intellectual Product]

Phrase: "protects"

Phrase: "CHO cells from apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "cultured in a serum-free environment"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0014406:Environment [Spatial Concept]
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   731   C0201230:Environmental culture [Laboratory Procedure]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "(Zhang et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.270: Therefore, we examined whether ligation of 51 to coated A1-40 would protect 51-expressing CHO cells from apoptosis in serum-free cultures. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "ligation of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023690:Ligation [Therapeutic or Preventive Procedure]

Phrase: "to coated A1-40"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1522408:Coated [Qualitative Concept]
   793 E C0453946:Coat [Manufactured Object]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "would"

Phrase: "protect"

Phrase: "51-expressing CHO cells from apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0085080:CHO Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in serum-free cultures."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0010453:Cultures [Idea or Concept]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.271: CHO-B2/51+ cells were plated on either fibronectin, vitronectin, or A-coated dishes and examined for survival 96h after serum withdrawal. 

Phrase: "CHO-B2/51+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on either fibronectin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "vitronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "or"

Phrase: "A-coated dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "examined for survival 96h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C0332128:Examined [Finding]

Phrase: "after serum withdrawal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
Processing 00000000.tx.272: CHO-B2/51+ cells survived on A and fibronectin, whereas cells plated on vitronectin underwent apoptosis (Fig. 10 B). 

Phrase: "CHO-B2/51+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "survived on A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "and"

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whereas"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "plated on vitronectin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336937:VITRONECTIN [Gene or Genome]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "underwent"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Fig. 10 B"

Phrase: ")."
Processing 00000000.tx.273: These results indicate that 51 can also protect cells from apoptosis by mediating cell attachment to coated A.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that 51"

Phrase: "can"

Phrase: "also"

Phrase: "protect"

Phrase: "cells from apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "by"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cell attachment to coated A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0887869:Cell Attachment [Cell Component]
   760   C0185023:Attachment [Therapeutic or Preventive Procedure]
   760   C1947904:Attachment [Activity]
   760   C1999228:Attachment [Intellectual Product]
Processing 00000000.tx.274: Discussion Top Abstract Introduction Materials & Methods Results Discussion References We report that the 51 integrin mediates cell adhesion to A and promotes internalization and degradation of A. 

Phrase: "Discussion Top Abstract Introduction Materials & Methods Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell adhesion to A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "degradation of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
Processing 00000000.tx.275: This 51-A interaction correlates with both an increase in the clearance of soluble A, a reduction in the formation of an insoluble A fibrillar matrix, and a decrease of the toxicity of A to cells. 

Phrase: "This 51-"

Phrase: "A interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "correlates with both"

Phrase: "an increase in the clearance of soluble A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "a reduction in the formation of an insoluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "A fibrillar matrix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "a decrease of the toxicity of A to cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.276: This study provides one mechanism for regulating A accumulation. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "one mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441712:Mechanism [Functional Concept]
   790   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "A accumulation."
Processing 00000000.tx.277: Our data, showing that A binds to 51, and to a lesser extent v1, is in agreement with previous reports that A mediates cell attachment, and that the RHD sequence in it serves as an integrin-binding site (Ghiso et al., 1992; Sabo et al., 1995). 

Phrase: "Our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "A"

Phrase: "binds to 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and to a lesser extent v1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439792:Extent [Spatial Concept]
   753   C0457422:V1 [Finding]
   753   C0507238:V1 [Body Part, Organ, or Organ Component]
   753   C0547044:Lesser [Qualitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Previous [Temporal Concept]
  1000   C1552607:previous [Temporal Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "A"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell attachment,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887869:Cell Attachment [Cell Component]
   861   C0185023:Attachment [Therapeutic or Preventive Procedure]
   861   C1947904:Attachment [Activity]
   861   C1999228:Attachment [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "the RHD sequence in it"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "serves as an integrin-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   790   C1149503:Integrin Binding [Molecular Function]
   753   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "(Ghiso et al.,"

Phrase: "1992"

Phrase: "; Sabo et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.278: The RHD sequence apparently functions as a mimic of the RGD sequence in fibronectin, the matrix ligand of 51 (Ruoslahti, 1996a), because a short peptide containing the RGD sequence inhibits A binding. 

Phrase: "The RHD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035439:rhd [Disease or Syndrome]
  1000   C1419382:RHD [Gene or Genome]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "functions as a"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]

Phrase: "mimic of the RGD sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C2699006:RGD [Intellectual Product]

Phrase: "in fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the matrix ligand of 51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023688:Ligand [Chemical]

Phrase: "(Ruoslahti,"

Phrase: "1996a"

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "a short peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the RGD sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]
Processing 00000000.tx.279: 51 binds only to nonfibrillar A, since we did not see any detectable cell adhesion to aggregated fibrillar A. 

Phrase: "51"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "only to nonfibrillar"

Phrase: "A,"

Phrase: "since"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "any detectable cell adhesion to aggregated fibrillar A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.280: Therefore, other receptors presumably mediate cellular interactions with fibrillar A, and are responsible for the cytotoxic effects of this form of A. 

Phrase: "Therefore,"

Phrase: "other receptors presumably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cellular interactions with fibrillar A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "responsible for the cytotoxic effects of this form of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]
Processing 00000000.tx.281: The 51 integrin is one of the most discriminating of the RGD-directed integrins with regard to its ligand specificity (Ruoslahti, 1996b). 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "is"

Phrase: "one of the most discriminating of the RGD-directed integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "with regard to its ligand specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "(Ruoslahti,"

Phrase: "1996b"

Phrase: ")."
Processing 00000000.tx.282: In addition to its main ligand fibronectin, the 51 integrin has only been shown to bind to the bacterial protein invasin (Watari et al., 1996) and the insulin-like growth factor binding protein IGFBP-X (Jones et al., 1993). 

Phrase: "In addition to its main ligand fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to the bacterial protein invasin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004627:Protein, Bacterial [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0020197:invasin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0521009:Bacterial [Qualitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]

Phrase: "(Watari et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "and"

Phrase: "the insulin-like growth factor binding protein IGFBP-X (Jones et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.283: Our results add A among its ligands. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "add"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883712:Add [Functional Concept]

Phrase: "A among its ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023688:Ligands [Chemical]
Processing 00000000.tx.284: The binding site for 51 seems to be available only in A, not in its precursor protein (APP; B.Bossy, M.L. Matter, and E.Ruoslahti, unpublished results). 

Phrase: "The binding site for 51"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "available only in A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0470187:Available [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "not in its precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1518422:Not [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "; B.Bossy, M.L. Matter,"

Phrase: "and"

Phrase: "E.Ruoslahti,"

Phrase: "unpublished results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ")."
Processing 00000000.tx.285: The 51 integrin may play a role in the rapid clearance of A that occurs in the normal brain (Ghersi-Egea et al., 1996). 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the rapid clearance of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "occurs in the normal brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1709305:Occur [Activity]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(Ghersi-Egea et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.286: We show that expression of the 51 integrin is associated with increased cellular uptake and degradation and decreased matrix deposition of A in cell cultures. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that expression of the 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with increased cellular uptake"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "decreased matrix deposition of A in cell cultures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.287: Moreover, reversal of this effect with a function-blocking anti-5 antibody established a causal link between 51 activity and increased clearance of A. 

Phrase: "Moreover,"

Phrase: "reversal of this effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443290:Reversal [Functional Concept]

Phrase: "with a function-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "anti-5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a causal link between 51 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "increased clearance of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.288: Although more complex explanations of this effect are possible, the binding of A to 51 shown here suggests that A binds to 51 at the cell surface, and is subsequently internalized into a cellular compartment where it is degraded. 

Phrase: "Although"

Phrase: "more complex explanations of this effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]

Phrase: "are"

Phrase: "possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "the binding of A to 51"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "A"

Phrase: "binds to 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "at the cell surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "subsequently"

Phrase: "internalized into a cellular compartment where"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2986730:Compartment [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.289: This hypothesis is in agreement with previous results showing that a neuronal cell line internalizes A from culture medium in a manner that is dependent on the NH2 terminus of A where the RHD sequence resides (Ida et al., 1996). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a neuronal cell line"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "internalizes"

Phrase: "A from culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C2242979:Culture [Laboratory Procedure]
   770   C3244283:medium [Intellectual Product]

Phrase: "in a manner"

Phrase: "that"

Phrase: "is"

Phrase: "dependent on the NH2 terminus of A where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "the RHD sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "resides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "(Ida et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.290: The lipoprotein Apo J can also reduce the formation of fibrillar A by causing it to be internalized and degraded (Hammad et al., 1997). 

Phrase: "The lipoprotein Apo J"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0055966:Apo-J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1413514:APOJ [Gene or Genome]
   901   C2609437:APOJ [Laboratory Procedure]
   901   C2827446:APOJ [Gene or Genome]

Phrase: "can"

Phrase: "also"

Phrase: "reduce"

Phrase: "the formation of fibrillar A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "by causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "internalized"

Phrase: "and"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(Hammad et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.291: Thus, it is likely that more than one mechanism plays a role in the regulation of A accumulation in vivo. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that more than one mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205447:One [Quantitative Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the regulation of A accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.292: Clearly, a transgenic animal expressing the amyloid precursor protein with a mutated RHD sequence would be of great interest in testing the contribution of the RHD sequence and integrin-binding to the metabolism of A. 

Phrase: "Clearly,"

Phrase: "a transgenic animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Transgenic Animal [Animal]
   861   C0003062:Animal [Animal]

Phrase: "expressing"

Phrase: "the amyloid precursor protein with a mutated RHD sequence"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   781   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0002518:Protein Sequence [Amino Acid Sequence]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "would"

Phrase: "be of great interest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0543488:Interest [Mental Process]
   770   C0549177:Great [Quantitative Concept]
   770   C1704243:Great [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "in testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]

Phrase: "the contribution of the RHD sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "integrin-binding to the metabolism of A."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1149503:Integrin Binding [Molecular Function]
   748   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.293: The 51 integrin circulates through the endocytic cycle (Bretscher, 1989; Bretscher, 1992). 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "circulates through the endocytic cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175630:circulate [Functional Concept]
   760   C1511572:Cycle [Temporal Concept]

Phrase: "(Bretscher,"

Phrase: "1989"

Phrase: "; Bretscher,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.294: Inhibiting exocytosis with primaquin causes accumulation of internalized 51 in an intracellular pool that returns to the cell surface over time. 

Phrase: "Inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "exocytosis with primaquin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015283:Exocytosis [Cell Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "accumulation of internalized 51"

Phrase: "in an intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "that returns to the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0332156:Return to [Qualitative Concept]
           Return

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.295: Recent studies have shown that internalization of fibrillar A promotes accumulation of stable fibrillar A in the late endosome/secondary lysosome compartment, whereas internalization of soluble A leads to degradation of the peptide in the same compartment (Knauer et al., 1992; Koo and Squazzo, 1994; Yang et al., 1995). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that internalization of fibrillar A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "accumulation of stable fibrillar A"

Phrase: "in the late endosome/secondary lysosome compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185625:Compartment [Body Space or Junction]
   804   C2986730:Compartment [Spatial Concept]

Phrase: "whereas"

Phrase: "internalization of soluble A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0871786:internalization [Mental Process]

Phrase: "leads to degradation of the peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C1523817:peptide degradation [Molecular Function]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0181586:leads [Medical Device]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the same compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "(Knauer et al.,"

Phrase: "1992"

Phrase: "; Koo"

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "1994"

Phrase: "; Yang et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.296: This result is in agreement with our data, showing that soluble A is internalized through an 51 integrin-mediated pathway, and is at least partially degraded, presumably within endosomes. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that soluble A"

Phrase: "is"

Phrase: "internalized through an 51 integrin-mediated pathway,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "is at least partially"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ","

Phrase: "presumably within endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.297: Thus, clearance of soluble A can be mediated by the 51 integrin, presumably through the receptor-mediated endocytosis pathway that normally internalizes this integrin. 

Phrase: "Thus,"

Phrase: "clearance of soluble A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by the 51 integrin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "presumably through the receptor-mediated endocytosis pathway"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0597361:Receptor Mediated Endocytosis [Cell Function]
   778   C2984285:Endocytosis Pathway [Functional Concept]
           Endocytosis
   748   C0014139:Endocytosis [Cell Function]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "that normally"

Phrase: "internalizes"

Phrase: "this integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.298: 51 may play a protective role in the brain by suppressing A cytotoxicity. 

Phrase: "51"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a protective role in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "by suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "A cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.299: We provide evidence for two separate mechanisms that could be responsible for such a protective effect. 

Phrase: "We"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for two separate mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "responsible for such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "a protective effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.300: First, we show that 51-mediated adhesion to nonfibrillar A protects cells from apoptosis in cell culture. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 51-mediated adhesion to nonfibrillar A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001511:Adhesion [Pathologic Function]
   748   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "protects"

Phrase: "cells from apoptosis in cell culture."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0007585:cells culture [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.301: Upregulation of Bcl-2 (Zhang et al., 1995) and activation of the MAPK pathway (Wary et al., 1997) may be responsible for this pathway. 

Phrase: "Upregulation of Bcl-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "(Zhang et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "activation of the MAPK pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1155551:MAPK activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "(Wary et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "responsible for this pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.302: The second and potentially more important mechanism is suggested by our demonstration that 51 suppresses the apoptotic effects of A by reducing production of toxic A matrix. 

Phrase: "The second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "potentially more important mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "suggested by our demonstration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1705535:Suggest [Idea or Concept]

Phrase: "that 51"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the apoptotic effects of A by reducing production of toxic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   741   C0600688:Toxic effect [Injury or Poisoning]
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "A matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]
Processing 00000000.tx.303: The 51 integrin and v1 are present in the adult central nervous system (Grooms et al., 1993). 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "v1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0457422:V1 [Finding]
  1000   C0507238:V1 [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "present in the adult central nervous system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "(Grooms et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.304: Immunostaining for 51 shows that it is expressed in the vasculature, cortex, and hippocampus of adult rat brain (Bahr et al., 1991; Pagani et al., 1992; Tawil et al., 1994; for review see Sargent Jones, 1996). 

Phrase: "Immunostaining for 51"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "expressed in the vasculature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus of adult rat brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0019564:BRAIN, HIPPOCAMPUS [Body Part, Organ, or Organ Component]
           Hippocampus
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Bahr et al.,"

Phrase: "1991"

Phrase: "; Pagani et al.,"

Phrase: "1992"

Phrase: "; Tawil et al.,"

Phrase: "1994"

Phrase: ";"

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Sargent Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.305: Moreover, primary hippocampal neurons express 51 (Yamazaki et al., 1997). 

Phrase: "Moreover,"

Phrase: "primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "51"

Phrase: "(Yamazaki et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.306: Soluble A1-40 is present in vivo (Seubert et al., 1992), and is rapidly cleared when injected into normal rats (Ghersi-Egea et al., 1996). 

Phrase: "Soluble A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439509:/40 [Temporal Concept]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "is"

Phrase: "present in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Seubert et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "when"

Phrase: "injected into normal rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C1720154:Inject [Functional Concept]

Phrase: "(Ghersi-Egea et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.307: Our results suggest that 51 may mediate the clearance of A, and that 51 may play a significant role in protecting the brain from the A-initiated pathology that in its extreme form causes AD.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 51"

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the clearance of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "that 51"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a significant role in protecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the brain from the A-initiated pathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0006119:Brain Pathology [Pathologic Function]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "that in its extreme form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205403:Extreme [Qualitative Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "AD."
Processing 00000000.tx.308: Footnotes Received for publication 2 December 1997 and in revised form 25 February 1998.  

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "Received for publication 2 December 1997"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and in revised form 25 February 1998."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1515981:And [Idea or Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
Processing 00000000.tx.309: The present address of Z.Zhang is Department of Neurobiology, Harvard Medical School, The Children's Hospital, Enders 260, 300Longwood Ave., Boston, MA 02115.  

Phrase: "The present address of Z.Zhang"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0376649:Address [Intellectual Product]
   753   C1442065:Address [Spatial Concept]

Phrase: "is"

Phrase: "Department of Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "The Children's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020017:Children's hospital [Health Care Related Organization]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Enders 260,"

Phrase: "300Longwood Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115."
Processing 00000000.tx.310: Address all correspondence to Erkki Ruoslahti, The Burnham Institute, 10901North Torrey Pines Rd., La Jolla, CA 90237.Tel.: 

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence to Erkki Ruoslahti,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282413:Correspondence [Intellectual Product]

Phrase: "The Burnham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "10901North Torrey Pines Rd.,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 90237.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.311: 619-646-3125; 

Phrase: "619-646-3125"

Phrase: ";"
Processing 00000000.tx.312: Fax: 619-646-3199; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "619-646-3199"

Phrase: ";"
Processing 00000000.tx.313: E-mail: ruoslahti{at}burnham-inst.org We thank Drs. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ruoslahti{at}burnham-inst.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1522486:ORG [Professional or Occupational Group]

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.314: Blaise Bossy, Eva Engvall, and Kristiina Vuori for comments on the manuscript, and Dr. 

Phrase: "Blaise Bossy, Eva Engvall,"

Phrase: "and"

Phrase: "Kristiina Vuori for comments"

Phrase: "on the manuscript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.315: Edward Monosov for help with the confocal microscopy. 

Phrase: "Edward Monosov for"

Phrase: "help with the confocal microscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   760   C0018896:Help [Social Behavior]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C1552861:help [Idea or Concept]
Processing 00000000.tx.316: This work was supported by grant CA28896 (E.Ruoslahti) and Cancer Center Support Grant CA 30199 from the National Cancer Institute, Department of Health and Human Services. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grant CA28896"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "(E.Ruoslahti"

Phrase: ")"

Phrase: "and"

Phrase: "Cancer Center Support Grant CA 30199 from the National Cancer Institute,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C1516176:Cancer Center Support Grant [Governmental or Regulatory Activity]
   775   C1513882:National Cancer Institute [Health Care Related Organization]
   756   C1513817:Cancer Center [Health Care Related Organization]
   754   C0006826:CA - Cancer [Neoplastic Process]
           Cancer
   738   C0018173:Grant [Quantitative Concept]
   738   C0021622:institute [Organization]
   738   C0183683:Support [Medical Device]
   738   C0205099:Center [Spatial Concept]
   738   C0998265:Cancer [Eukaryote]
   738   C1272753:Institute [Idea or Concept]
   738   C1306459:Cancer [Finding]
   738   C1521721:Support [Conceptual Entity]
   738   C1548284:Grant [Idea or Concept]
   738   C3245503:national [Intellectual Product]

Phrase: "Department of Health and Human Services."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   858   C0018747:Health Services [Health Care Activity]
   827   C0037440:human services [Self-help or Relief Organization]
   799   C0018684:Health [Idea or Concept]
   799   C0086418:Human [Human]
   799   C0557854:Services [Occupational Activity]
   799   C1704729:Department [Organization]
   766 E C2825316:Service [Manufactured Object]
   766 E C3245478:service [Idea or Concept]
Processing 00000000.tx.317: M.L. 

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: Matter is supported by postdoctoral training grant CA09579 from the National Institutes of Health.  

Phrase: "Matter"

Phrase: "is"

Phrase: "supported by postdoctoral training grant CA09579"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0555633:Training grant [Intellectual Product]
   767   C0040608:Training Support [Educational Activity]
   753   C0018173:Grant [Quantitative Concept]
   753   C0040607:Training [Educational Activity]
   753   C0220931:Training [Educational Activity]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C2673163:training [Qualitative Concept]
   719 E C0183683:Support [Medical Device]
   719 E C0336809:Train [Manufactured Object]
   719 E C1552514:Train [Manufactured Object]

Phrase: "from the National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.319: Abbreviations used in this paper A, amyloid peptide; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper A,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0030351:Paper [Manufactured Object]
   760   C1273517:used [Finding]
   760   C1547566:Paper [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.320: AD, Alzheimer's disease, LDH, lactate dehydrogenase; 

Phrase: "AD,"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "LDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.321: RHD, arg-his-asp.  

Phrase: "RHD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035439:rhd [Disease or Syndrome]
  1000   C1419382:RHD [Gene or Genome]

Phrase: "arg-"

Phrase: "his-asp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]
Processing 00000000.tx.322: References Top Abstract Introduction Materials & Methods Results Discussion References 1. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.323: Bahr, B.A., A. 

Phrase: "Bahr,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.324: Sheppard, P.W. 

Phrase: "Sheppard,"

Phrase: "P.W."
Processing 00000000.tx.325: Vanderklish, B.L. 

Phrase: "Vanderklish,"

Phrase: "B.L."
Processing 00000000.tx.326: Bakus, D. 

Phrase: "Bakus,"

Phrase: "D."
Processing 00000000.tx.327: Capaldi, and G. 

Phrase: "Capaldi,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.328: Lynch. 

Phrase: "Lynch."
Processing 00000000.tx.329: 1991. 

Phrase: "1991."
Processing 00000000.tx.330: Antibodies to the alpha v beta 3integrin label a protein concentrated in brain synaptosomal membranes. 

Phrase: "Antibodies to the alpha v beta 3integrin label"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0370124:V Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "concentrated in brain synaptosomal membranes."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0025255:Membranes [Tissue]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]
Processing 00000000.tx.331: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.332: 2: 321-324 2. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "321-324 2."
Processing 00000000.tx.333: Bauer, J.S., C.L. 

Phrase: "Bauer,"

Phrase: "J.S.,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.334: Schreiner, F.G. 

Phrase: "Schreiner,"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.335: Giancotti, E. 

Phrase: "Giancotti,"

Phrase: "E."
Processing 00000000.tx.336: Ruoslahti, and R.L. 

Phrase: "Ruoslahti,"

Phrase: "and"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.337: Juliano. 

Phrase: "Juliano."
Processing 00000000.tx.338: 1992. 

Phrase: "1992."
Processing 00000000.tx.339: Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. 

Phrase: "Motility of fibronectin receptor-deficient cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0007608:cell motility [Cell Function]
           Motility
   753   C0678835:Motility [Laboratory or Test Result]
   753   C1510470:Motility [Organism Function]

Phrase: "on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: ":"

Phrase: "collaborative interactions among integrins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.340: J. 

Phrase: "J."
Processing 00000000.tx.341: Cell Biol 116: 477-487 [Abstract]. 

Phrase: "Cell Biol 116"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "477-487"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.342: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.343: Behl, C., J.B. 

Phrase: "Behl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "J.B."
Processing 00000000.tx.344: Davis, R. 

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.345: Lesley, and D. 

Phrase: "Lesley,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.346: Schubert. 

Phrase: "Schubert."
Processing 00000000.tx.347: 1994. 

Phrase: "1994."
Processing 00000000.tx.348: Hydrogen peroxide mediates amyloid protein toxicity. 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "amyloid protein toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.349: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.350: 77: 817-827 4. 

Phrase: "77"

Phrase: ":"

Phrase: "817-827 4."
Processing 00000000.tx.351: Bretscher, M.S.. 

Phrase: "Bretscher,"

Phrase: "M.S.."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.352: 1992. 

Phrase: "1992."
Processing 00000000.tx.353: Circulating integrins: alpha 5beta 1,alpha 6beta 4and Mac-1, but not alpha 3beta 1,alpha 4beta 1or LFA-1. 

Phrase: "Circulating integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ":"

Phrase: "alpha 5beta 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "alpha 6beta 4and Mac-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   840   C0079785:Mac 1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C3538559:MAC [Cell Component]

Phrase: "but"

Phrase: "not alpha 3beta 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   812   C0439095:Alpha [Intellectual Product]
   812   C1518422:Not [Functional Concept]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]

Phrase: "alpha 4beta 1or LFA-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   840   C0079717:LFA 1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.354: EMBO (Eur. Mol. Biol. Organ.) 

Phrase: "EMBO"

Phrase: "(Eur. Mol. Biol. Organ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: ")"
Processing 00000000.tx.355: J 11: 405-410 [Abstract]. 

Phrase: "J 11"

Phrase: ":"

Phrase: "405-410"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.356: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.357: Bretscher, M.S.. 

Phrase: "Bretscher,"

Phrase: "M.S.."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: 1989. 

Phrase: "1989."
Processing 00000000.tx.359: Endocytosis and recycling of the fibronectin receptor in CHO cells. 

Phrase: "Endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "recycling of the fibronectin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0599282:receptor recycling [Cell Function]
   760   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "in CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.360: EMBO (Eur. Mol. Biol. Organ.) 

Phrase: "EMBO"

Phrase: "(Eur. Mol. Biol. Organ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: ")"
Processing 00000000.tx.361: J 8: 1341-1348 [Abstract]. 

Phrase: "J 8"

Phrase: ":"

Phrase: "1341-1348"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.362: 6. 

Phrase: "6."
Processing 00000000.tx.363: Bush, A.I., W.H. 

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.364: Pettingell, G. 

Phrase: "Pettingell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.365: Multhaup, M.D. 

Phrase: "Multhaup,"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.366: Paradis, J.-P. 

Phrase: "Paradis,"

Phrase: "J.-P."
Processing 00000000.tx.367: Vonsattel, J.F. 

Phrase: "Vonsattel,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.368: Gusella, K. 

Phrase: "Gusella,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.369: Beyreuther, C.L. 

Phrase: "Beyreuther,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.370: Masters, and R.E. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "and"

Phrase: "R.E."
Processing 00000000.tx.371: Tanzi. 

Phrase: "Tanzi."
Processing 00000000.tx.372: 1994. 

Phrase: "1994."
Processing 00000000.tx.373: Rapid induction of Alzheimer A amyloid formation by zinc. 

Phrase: "Rapid induction of Alzheimer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "A amyloid formation by zinc."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.374: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.375: 265: 1464-1467 7. 

Phrase: "265"

Phrase: ":"

Phrase: "1464-1467 7."
Processing 00000000.tx.376: Citron, M., T. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.377: Oltersdorf, C. 

Phrase: "Oltersdorf,"

Phrase: "C."
Processing 00000000.tx.378: Haass, L. 

Phrase: "Haass,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.379: McConlogue, A.Y. 

Phrase: "McConlogue,"

Phrase: "A.Y."
Processing 00000000.tx.380: Hung, P. 

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.381: Seubert, C. 

Phrase: "Seubert,"

Phrase: "C."
Processing 00000000.tx.382: Vigo-Pelfrey, I. 

Phrase: "Vigo-Pelfrey,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.383: Lieberburg, and D.J. 

Phrase: "Lieberburg,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.384: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.385: 1992. 

Phrase: "1992."
Processing 00000000.tx.386: Mutation of the -amyloid precursor protein in familial Alzheimer's disease increases -protein production. 

Phrase: "Mutation of the -amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial Alzheimer's disease increases -protein production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]
Processing 00000000.tx.387: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.388: 360: 672-674 8. 

Phrase: "360"

Phrase: ":"

Phrase: "672-674 8."
Processing 00000000.tx.389: Citron, M., T.S. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "T.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.390: Diehl, G. 

Phrase: "Diehl,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: Gordon, A.L. 

Phrase: "Gordon,"

Phrase: "A.L."
Processing 00000000.tx.392: Biere, P. 

Phrase: "Biere,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.393: Seubert, and D.J. 

Phrase: "Seubert,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.394: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.395: 1996. 

Phrase: "1996."
Processing 00000000.tx.396: Evidence that the 42-and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the 42-"

Phrase: "and"

Phrase: "40-amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "forms of amyloid beta protein"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   862   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   806   C1750295:beta protein [Genetic Function]
   806   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   806   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797 E C2825879:Amyloid, Beta [Laboratory Procedure]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0330390:Beta [Plant]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0439096:Beta [Intellectual Product]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1522492:Form [Functional Concept]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "are"

Phrase: "generated from the beta-amyloid precursor protein"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   853   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   831 E C3538722:Amyloid Beta Precursor Protein [Laboratory Procedure]
           Amyloid Precursor Protein
           Amyloid Precursor Beta
   804   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2825879:Amyloid, Beta [Laboratory Procedure]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1750295:beta protein [Genetic Function]
   774   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   774 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C2004068:Beta [Qualitative Concept]
   748   C3146294:Generated [Activity]

Phrase: "by different protease activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1150095:protease activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.397: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.398: Natl. 

Phrase: "Natl."
Processing 00000000.tx.399: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.400: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.401: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.402: 93: 13170-13175 [Abstract/Free FullText]. 

Phrase: "93"

Phrase: ":"

Phrase: "13170-13175"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.403: 9. 

Phrase: "9."
Processing 00000000.tx.404: Cotter, T.G., and S.J. 

Phrase: "Cotter,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and S.J."
Processing 00000000.tx.405: Martin. 

Phrase: "Martin."
Processing 00000000.tx.406: 1996.

Phrase: "1996."
Processing 00000000.tx.407: Techniques in Apoptosis. 

Phrase: "Techniques in Apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0025664:techniques [Intellectual Product]
   790   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.408: Portland Press Ltd., London. 

Phrase: "Portland Press Ltd.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1136140:LTD [Organ or Tissue Function]

Phrase: "London."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]
Processing 00000000.tx.409: 333pp. 

Phrase: "333pp."
Processing 00000000.tx.410: 10. 

Phrase: "10."
Processing 00000000.tx.411: Duckworth, W.C., M. 

Phrase: "Duckworth,"

Phrase: "W.C., M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: Heinemann, and A.E. 

Phrase: "Heinemann,"

Phrase: "and"

Phrase: "A.E."
Processing 00000000.tx.413: Kitabchi. 

Phrase: "Kitabchi."
Processing 00000000.tx.414: 1972. 

Phrase: "1972."
Processing 00000000.tx.415: Purification of insulin-specific protease by affinity chromatography. 

Phrase: "Purification of insulin-specific protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "by affinity chromatography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   761 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.416: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.417: Natl. 

Phrase: "Natl."
Processing 00000000.tx.418: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.419: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.420: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.421: 69: 3698-3702 [Abstract]. 

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "3698-3702"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.422: 11. 

Phrase: "11."
Processing 00000000.tx.423: Frisch, S., and E. 

Phrase: "Frisch,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.424: Ruoslahti. 

Phrase: "Ruoslahti."
Processing 00000000.tx.425: 1997. 

Phrase: "1997."
Processing 00000000.tx.426: Integrins and anoikis. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "anoikis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872097:Anoikis [Cell Function]
Processing 00000000.tx.427: Curr. 

Phrase: "Curr."
Processing 00000000.tx.428: Opin. 

Phrase: "Opin."
Processing 00000000.tx.429: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.430: 9: 701-706 12. 

Phrase: "9"

Phrase: ":"

Phrase: "701-706 12."
Processing 00000000.tx.431: Ghersi-Egea, J.F., P.D. 

Phrase: "Ghersi-Egea,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "P.D."
Processing 00000000.tx.432: Gorevic, J. 

Phrase: "Gorevic,"

Phrase: "J."
Processing 00000000.tx.433: Ghiso, B. 

Phrase: "Ghiso,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: Frangione, C.S. 

Phrase: "Frangione,"

Phrase: "C.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.435: Patlak, and J.D. 

Phrase: "Patlak,"

Phrase: "and"

Phrase: "J.D."
Processing 00000000.tx.436: Fenstermacher. 

Phrase: "Fenstermacher."
Processing 00000000.tx.437: 1996. 

Phrase: "1996."
Processing 00000000.tx.438: Fate of cerebrospinal fluid-borne amyloid -peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. 

Phrase: "Fate of cerebrospinal fluid-borne amyloid -peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1539479:FATE [Gene or Genome]

Phrase: ":"

Phrase: "rapid clearance into blood"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "appreciable accumulation by cerebral arteries."
Processing 00000000.tx.439: J. 

Phrase: "J."
Processing 00000000.tx.440: Neurochem 67: 880-883 13. 

Phrase: "Neurochem 67"

Phrase: ":"

Phrase: "880-883 13."
Processing 00000000.tx.441: Ghiso, G., A. 

Phrase: "Ghiso,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.442: Rostagno, J.E. 

Phrase: "Rostagno,"

Phrase: "J.E."
Processing 00000000.tx.443: Gardella, L. 

Phrase: "Gardella,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.444: Liem, P.D. 

Phrase: "Liem,"

Phrase: "P.D."
Processing 00000000.tx.445: Gorevic, and J. 

Phrase: "Gorevic,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.446: Frangione. 

Phrase: "Frangione."
Processing 00000000.tx.447: 1992. 

Phrase: "1992."
Processing 00000000.tx.448: A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. 

Phrase: "A 109-amino-acid C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "of Alzheimer's-disease amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   933   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   911   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a sequence, -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "RHDS-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035439:rhd [Disease or Syndrome]
  1000   C1419382:RHD [Gene or Genome]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.449: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: 288: 1053-1059 14. 

Phrase: "288"

Phrase: ":"

Phrase: "1053-1059 14."
Processing 00000000.tx.452: Glenner, G., and C.W. 

Phrase: "Glenner,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "C.W."
Processing 00000000.tx.453: Wong. 

Phrase: "Wong."
Processing 00000000.tx.454: 1984. 

Phrase: "1984."
Processing 00000000.tx.455: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "initial report of the purification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "characterization of a novel cerebrovascular amyloid protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]
Processing 00000000.tx.456: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.457: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.458: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.459: Commun. 

Phrase: "Commun."
Processing 00000000.tx.460: 120: 885-890 15. 

Phrase: "120"

Phrase: ":"

Phrase: "885-890 15."
Processing 00000000.tx.461: Gravina, S.A., L. 

Phrase: "Gravina,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.462: Ho, C.B. 

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.463: Eckman, K.E. 

Phrase: "Eckman,"

Phrase: "K.E."
Processing 00000000.tx.464: Long, L. 

Phrase: "Long, L."
Processing 00000000.tx.465: Otvos, L.H. 

Phrase: "Otvos,"

Phrase: "L.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.466: Younkin, N. 

Phrase: "Younkin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.467: Suzuki, and S.G. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "and S.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.468: Younkin. 

Phrase: "Younkin."
Processing 00000000.tx.469: 1995. 

Phrase: "1995."
Processing 00000000.tx.470: Amyloid protein (A) in Alzheimer's disease brain. 

Phrase: "Amyloid protein (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in Alzheimer's disease brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.471: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A40 or A42. 

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "immunocytochemical analysis with antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "specific for forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "ending at A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444930:ending [Spatial Concept]
   790   C2746065:Ending [Temporal Concept]

Phrase: "or"

Phrase: "A42."
Processing 00000000.tx.472: J. 

Phrase: "J."
Processing 00000000.tx.473: Biol. 

Phrase: "Biol."
Processing 00000000.tx.474: Chem 270: 7013-7016 [Abstract/Free FullText]. 

Phrase: "Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "7013-7016"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.475: 16. 

Phrase: "16."
Processing 00000000.tx.476: Grooms, S.Y., L. 

Phrase: "Grooms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0018249:groom [Individual Behavior]
   966   C0518461:groom [Finding]

Phrase: "S."

Phrase: "Y.,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.477: Terracio, L. 

Phrase: "Terracio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.478: Sargent, and Jones. 

Phrase: "Sargent,"

Phrase: "and"

Phrase: "Jones."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]
Processing 00000000.tx.479: 1993. 

Phrase: "1993."
Processing 00000000.tx.480: Anatomical localization of 1 integrin-like immunoreactivity in rat brain. 

Phrase: "Anatomical localization of 1 integrin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.481: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.482: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.483: 122: 253-259 17. 

Phrase: "122"

Phrase: ":"

Phrase: "253-259 17."
Processing 00000000.tx.484: Hammad, S.M., S. 

Phrase: "Hammad,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.485: Ranganathan, E. 

Phrase: "Ranganathan,"

Phrase: "E."
Processing 00000000.tx.486: Loukinova, W.O. 

Phrase: "Loukinova,"

Phrase: "W.O."
Processing 00000000.tx.487: Twal, and W.S. 

Phrase: "Twal,"

Phrase: "and"

Phrase: "W.S."
Processing 00000000.tx.488: Argraves. 

Phrase: "Argraves."
Processing 00000000.tx.489: 1997. 

Phrase: "1997."
Processing 00000000.tx.490: Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. 

Phrase: "Interaction of apolipoprotein J-amyloid beta-peptide complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "with low density lipoprotein receptor-related protein-2/megalin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0284555:Low Density Lipoprotein Receptor-Related Protein-2 [Amino Acid, Peptide, or Protein,Receptor]
           Megalin
   793   C1416914:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2 [Gene or Genome]
           MEGALIN
   725   C0023170:Low-Density Lipoprotein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
Processing 00000000.tx.491: A mechanism to prevent pathological accumulation of amyloid beta-peptide. 

Phrase: "A mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "pathological accumulation of amyloid beta-peptide."
Processing 00000000.tx.492: J. 

Phrase: "J."
Processing 00000000.tx.493: Biol. 

Phrase: "Biol."
Processing 00000000.tx.494: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.495: 272: 18644-18649 [Abstract/Free FullText]. 

Phrase: "272"

Phrase: ":"

Phrase: "18644-18649"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.496: 18. 

Phrase: "18."
Processing 00000000.tx.497: Ida, N., C.L. 

Phrase: "Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.498: Masters, and K. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.499: Beyreuther. 

Phrase: "Beyreuther."
Processing 00000000.tx.500: 1996. 

Phrase: "1996."
Processing 00000000.tx.501: Rapid cellular uptake of Alzheimer amyloid betaA4 peptide by cultured human neuroblastoma cells. 

Phrase: "Rapid cellular uptake of Alzheimer amyloid betaA4 peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "by cultured human neuroblastoma cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.502: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.503: 394: 174-178 19. 

Phrase: "394"

Phrase: ":"

Phrase: "174-178 19."
Processing 00000000.tx.504: Jarret, J.T., E.P. 

Phrase: "Jarret,"

Phrase: "J.T.,"

Phrase: "E.P."
Processing 00000000.tx.505: Berger, and P.T. 

Phrase: "Berger,"

Phrase: "and"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.506: Lansbury. 

Phrase: "Lansbury."
Processing 00000000.tx.507: 1993. 

Phrase: "1993."
Processing 00000000.tx.508: The carboxy terminus of the -amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. 

Phrase: "The carboxy terminus of the -amyloid protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596260:Carboxy [Organic Chemical]

Phrase: "is"

Phrase: "critical for the seeding of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]

Phrase: ":"

Phrase: "implications for the pathogenesis of Alzheimer's disease."
Processing 00000000.tx.509: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.510: 32: 4693-4697 20. 

Phrase: "32"

Phrase: ":"

Phrase: "4693-4697 20."
Processing 00000000.tx.511: Jones, J.I., A. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "J.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A."
Processing 00000000.tx.512: Gockerman, W.H. 

Phrase: "Gockerman,"

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.513: Busby, G. 

Phrase: "Busby,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.514: Wright, and D.R. 

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: Clemons. 

Phrase: "Clemons."
Processing 00000000.tx.516: 1993. 

Phrase: "1993."
Processing 00000000.tx.517: Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the alpha 5beta 1integrin by means of its Arg-Gly-Asp sequence. 

Phrase: "Insulin-like growth factor binding protein-1"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
  1000   C0123256:Insulin-Like Growth-Factor Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334092:INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1 [Gene or Genome]
   954   C0074825:Insulin-like growth factor binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   927   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   913   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C1623517:insulin binding [Molecular Function]
   845   C1149299:Growth Factor Binding [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "binds to the alpha 5beta 1integrin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439095:Alpha [Intellectual Product]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C2003941:Alpha [Intellectual Product]
   753   C2350010:Alpha [Qualitative Concept]

Phrase: "by means of its Arg-Gly-Asp sequence."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C0052350:Arg-Gly-Asp [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.518: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.519: Natl. 

Phrase: "Natl."
Processing 00000000.tx.520: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.521: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.522: USA 90: 10553-10557 [Abstract]. 

Phrase: "USA 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041703:USA [Geographic Area]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "10553-10557"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.523: 21. 

Phrase: "21."
Processing 00000000.tx.524: Kang, J., H.G. 

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "H.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.525: Lemaire, A. 

Phrase: "Lemaire,"

Phrase: "A."
Processing 00000000.tx.526: Unterbeck, J.M. 

Phrase: "Unterbeck,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.527: Salbaum, C.L. 

Phrase: "Salbaum,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.528: Masters, K.H. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.529: Grzeschik, G. 

Phrase: "Grzeschik,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.530: Multhaup, K. 

Phrase: "Multhaup,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.531: Beyreuther, and B. 

Phrase: "Beyreuther,"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.532: Muller-Hill. 

Phrase: "Muller-Hill."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]
Processing 00000000.tx.533: 1987. 

Phrase: "1987."
Processing 00000000.tx.534: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. 

Phrase: "The precursor of Alzheimer's disease amyloid A4 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C0085151:Amyloid A4 Protein Precursor [Amino Acid, Peptide, or Protein]
           Amyloid Protein Precursor
   789   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   789   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "resembles"

Phrase: "a cell-surface receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0699040:Cell surface [Cell Component]
   812   C0205148:Surface [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.535: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.536: 325: 733-736 22. 

Phrase: "325"

Phrase: ":"

Phrase: "733-736 22."
Processing 00000000.tx.537: Khoury, J.H., S.E. 

Phrase: "Khoury,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.538: Hickman, C.A. 

Phrase: "Hickman,"

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.539: Thomas, L. 

Phrase: "Thomas,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.540: Cao, S.C. 

Phrase: "Cao,"

Phrase: "S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.541: Silverstein, and J.D. 

Phrase: "Silverstein,"

Phrase: "and"

Phrase: "J.D."
Processing 00000000.tx.542: Loike. 

Phrase: "Loike."
Processing 00000000.tx.543: 1996. 

Phrase: "1996."
Processing 00000000.tx.544: Scavenger receptor-mediated adhesion of microglia to -amyloid fibrils. 

Phrase: "Scavenger receptor-mediated adhesion of microglia to -amyloid fibrils."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0300500:adhesion receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.545: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.546: 382: 716-719 23. 

Phrase: "382"

Phrase: ":"

Phrase: "716-719 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.547: Knauer, M.F., B. 

Phrase: "Knauer,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.548: Soreghan, D. 

Phrase: "Soreghan,"

Phrase: "D."
Processing 00000000.tx.549: Burdick, J. 

Phrase: "Burdick,"

Phrase: "J."
Processing 00000000.tx.550: Kosmoski, and C.G. 

Phrase: "Kosmoski,"

Phrase: "and"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.551: Glabe. 

Phrase: "Glabe."
Processing 00000000.tx.552: 1992. 

Phrase: "1992."
Processing 00000000.tx.553: Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/ protein. 

Phrase: "Intracellular accumulation"

Phrase: "and"

Phrase: "resistance to degradation of the Alzheimer amyloid A4/ protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0237834:Resistance [Mental Process]
   742   C1514892:Resistance [Physiologic Function]
   729   C0332325:Resistant to [Functional Concept]
Processing 00000000.tx.554: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.555: Natl. 

Phrase: "Natl."
Processing 00000000.tx.556: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.557: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.558: USA 89: 7437-7441 [Abstract]. 

Phrase: "USA 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "7437-7441"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.559: 24. 

Phrase: "24."
Processing 00000000.tx.560: Koo, E.H., and S.L. 

Phrase: "Koo,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and S.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.561: Squazzo. 

Phrase: "Squazzo."
Processing 00000000.tx.562: 1994. 

Phrase: "1994."
Processing 00000000.tx.563: Evidence that production and release of amyloid -protein involves the endocytic pathway. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "release of amyloid -protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "involves"

Phrase: "the endocytic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.564: J. 

Phrase: "J."
Processing 00000000.tx.565: Biol. 

Phrase: "Biol."
Processing 00000000.tx.566: Chem 269: 17386-17389 [Abstract/Free FullText]. 

Phrase: "Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "17386-17389"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.567: 25. 

Phrase: "25."
Processing 00000000.tx.568: Lorenzo, A., and B.A. 

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "and"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.569: Yanker. 

Phrase: "Yanker."
Processing 00000000.tx.570: 1994. 

Phrase: "1994."
Processing 00000000.tx.571: -amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. 

Phrase: "-amyloid neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "requires"

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "inhibited by Congo Red."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0009738:Congo [Geographic Area]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.572: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.573: Natl. 

Phrase: "Natl."
Processing 00000000.tx.574: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.575: USA 9: 12243-12247 . 26. 

Phrase: "USA 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "12243-12247 . 26."
Processing 00000000.tx.576: Loo, D.T., A. 

Phrase: "Loo,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A."
Processing 00000000.tx.577: Copani, C.J. 

Phrase: "Copani,"

Phrase: "C.J."
Processing 00000000.tx.578: Pike, E.R. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: Whittermore, A.J. 

Phrase: "Whittermore,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.580: Walencewicz, and C.W. 

Phrase: "Walencewicz,"

Phrase: "and"

Phrase: "C.W."
Processing 00000000.tx.581: Cotman. 

Phrase: "Cotman."
Processing 00000000.tx.582: 1993. 

Phrase: "1993."
Processing 00000000.tx.583: Apoptosis is induced by -amyloid in cultured central nervous system neurons. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "induced by -amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0205263:Induced [Functional Concept]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured central nervous system neurons."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   858   C0682701:Central neuron [Cell]
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
   717   C0927232:Central Nervous System [Body System]
   717   C1269563:Central nervous system [Body System]
Processing 00000000.tx.584: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.585: Natl. 

Phrase: "Natl."
Processing 00000000.tx.586: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.587: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.588: USA 90: 7951-7955 [Abstract/Free FullText]. 

Phrase: "USA 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041703:USA [Geographic Area]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "7951-7955"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.589: 27. 

Phrase: "27."
Processing 00000000.tx.590: Masters, C.L., G. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.591: Simms, N.A. 

Phrase: "Simms,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.592: Weinman, G. 

Phrase: "Weinman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.593: Multhaup, B.L. 

Phrase: "Multhaup,"

Phrase: "B.L."
Processing 00000000.tx.594: McDonald, and K. 

Phrase: "McDonald,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.595: Beyreuther. 

Phrase: "Beyreuther."
Processing 00000000.tx.596: 1985. 

Phrase: "1985."
Processing 00000000.tx.597: Amyloid plaque core protein in Alzheimer disease and Down syndrome. 

Phrase: "Amyloid plaque core protein in Alzheimer disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.598: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.599: Natl. 

Phrase: "Natl."
Processing 00000000.tx.600: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.601: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.602: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.603: 80: 4245-4249 . 28. 

Phrase: "80"

Phrase: ":"

Phrase: "4245-4249 . 28."
Processing 00000000.tx.604: Matter, M.L., and G.W. 

Phrase: "Matter,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "G.W."
Processing 00000000.tx.605: Laurie. 

Phrase: "Laurie."
Processing 00000000.tx.606: 1994. 

Phrase: "1994."
Processing 00000000.tx.607: A novel laminin E8 cell adhesion site required for lung alveolar formation in vitro. 

Phrase: "A novel laminin E8 cell adhesion site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0205145:Site [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1515974:Site [Body Location or Region]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C2825164:Site [Spatial Concept]

Phrase: "required for lung alveolar formation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   797   C2610581:lung formation [Organ or Tissue Function]
   760   C0024109:Lung [Body Part, Organ, or Organ Component]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0819757:LUNG [Tissue]
   760   C1278908:Lung [Body Part, Organ, or Organ Component]
   760   C1440080:Alveolar [Body Part, Organ, or Organ Component]
   760   C1514873:Required [Functional Concept]
   760   C1522492:Formation [Functional Concept]
   704 E C2707265:Pulmonary [Clinical Attribute]
   704 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.608: J. 

Phrase: "J."
Processing 00000000.tx.609: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.610: 124: 1083-1090 [Abstract]. 

Phrase: "124"

Phrase: ":"

Phrase: "1083-1090"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.611: 29. 

Phrase: "29."
Processing 00000000.tx.612: McDermott, J.R., and A.M. 

Phrase: "McDermott,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.613: Gisbon. 

Phrase: "Gisbon."
Processing 00000000.tx.614: 1997. 

Phrase: "1997."
Processing 00000000.tx.615: Degradation of Alzheimer's amyloid protein by human and rat brain peptidases: involvement of insulin- degrading enzyme. 

Phrase: "Degradation of Alzheimer's amyloid protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat brain peptidases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1947941:Peptidase [Enzyme]
   734   C1882598:Rat Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "involvement of insulin- degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.616: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.617: Res 22: 49-56 30. 

Phrase: "Res 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: ":"

Phrase: "49-56 30."
Processing 00000000.tx.618: McKeown-Longo, P.J., and D.F. 

Phrase: "McKeown-Longo,"

Phrase: "P.J.,"

Phrase: "and"

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.619: Mosher. 

Phrase: "Mosher."
Processing 00000000.tx.620: 1985. 

Phrase: "1985."
Processing 00000000.tx.621: Interaction of 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix assembly receptor of fibroblasts. 

Phrase: "Interaction of 70,000-mol-wt amino-terminal fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "of fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with the matrix assembly receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "of fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.622: J. 

Phrase: "J."
Processing 00000000.tx.623: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.624: Biol 100: 364-374 [Abstract]. 

Phrase: "Biol 100"

Phrase: ":"

Phrase: "364-374"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.625: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.626: Morla, A.O., and E. 

Phrase: "Morla,"

Phrase: "A.O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029408:a o [Disease or Syndrome]

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.627: Ruoslahti. 

Phrase: "Ruoslahti."
Processing 00000000.tx.628: 1992. 

Phrase: "1992."
Processing 00000000.tx.629: A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide. 

Phrase: "A fibronectin self-assembly site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "involved in fibronectin matrix assembly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: ":"

Phrase: "reconstruction in a synthetic peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020912:Reconstruction [Machine Activity]
   760   C0524865:Reconstruction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.630: J. 

Phrase: "J."
Processing 00000000.tx.631: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.632: Biol. 

Phrase: "Biol."
Processing 00000000.tx.633: 118: 421-429 [Abstract]. 

Phrase: "118"

Phrase: ":"

Phrase: "421-429"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.634: 32. 

Phrase: "32."
Processing 00000000.tx.635: Nordstedt, C., J. 

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.636: Nslund, L.O. 

Phrase: "Nslund,"

Phrase: "L.O."
Processing 00000000.tx.637: Tjernberg, A.R. 

Phrase: "Tjernberg,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.638: Karlstrm, J. 

Phrase: "Karlstrm,"

Phrase: "J."
Processing 00000000.tx.639: Thyberg, and L. 

Phrase: "Thyberg,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.640: Terenius. 

Phrase: "Terenius."
Processing 00000000.tx.641: 1994. 

Phrase: "1994."
Processing 00000000.tx.642: The Alzheimer A peptide develops protease resistance in association with its polymerization into fibrils. 

Phrase: "The Alzheimer"

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "develops"

Phrase: "protease resistance in association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "with its polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "into fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.643: J. 

Phrase: "J."
Processing 00000000.tx.644: Biol. 

Phrase: "Biol."
Processing 00000000.tx.645: Chem 269: 30773-30776 [Abstract/Free FullText]. 

Phrase: "Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30773-30776"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.646: 33. 

Phrase: "33."
Processing 00000000.tx.647: Neill, D., D. 

Phrase: "Neill,"

Phrase: "D."

Phrase: ","

Phrase: "D."
Processing 00000000.tx.648: Hughes, D.K. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.649: Edwardson, B.K. 

Phrase: "Edwardson,"

Phrase: "B.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.650: Rima, and D. 

Phrase: "Rima,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.651: Allsop. 

Phrase: "Allsop."
Processing 00000000.tx.652: 1994. 

Phrase: "1994."
Processing 00000000.tx.653: Human IMR-32 Neuroblastoma cells as a model cell line in Alzheimer's disease research. 

Phrase: "Human IMR-32 Neuroblastoma cells as a model cell line"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0682523:Human Cell Line [Cell]
   757   C0007600:cells line [Cell]
   757   C0427861:Human cells [Laboratory or Test Result]
   743   C0815000:neuroblastoma cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "in Alzheimer's disease research."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.654: J. 

Phrase: "J."
Processing 00000000.tx.655: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.656: 39: 482-493 . 34. 

Phrase: "39"

Phrase: ":"

Phrase: "482-493 . 34."
Processing 00000000.tx.657: O'Brien, V., S.M. 

Phrase: "O'Brien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "V.,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.658: Frisch, and R.L. 

Phrase: "Frisch,"

Phrase: "and"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.659: Juliano. 

Phrase: "Juliano."
Processing 00000000.tx.660: 1996. 

Phrase: "1996."
Processing 00000000.tx.661: Expression of the integrin 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. 

Phrase: "Expression of the integrin 5 subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HT29 colon carcinoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0282639:HT-29 Cells [Cell]
   844   C1518174:Carcinoma Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "triggered by serum deprivation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1444748:Triggered by [Qualitative Concept]
           Trigger
   770   C0229671:Serum [Body Substance]
   770   C0871712:Deprivation [Qualitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737   C0032930:Trigger [Clinical Attribute]
Processing 00000000.tx.662: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.663: Cell Res 224: 208-213 35. 

Phrase: "Cell Res 224"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "208-213 35."
Processing 00000000.tx.664: Pagani, F., L. 

Phrase: "Pagani,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.665: Zagato, D. 

Phrase: "Zagato,"

Phrase: "D."
Processing 00000000.tx.666: Coviello, and C. 

Phrase: "Coviello,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.667: Vergani. 

Phrase: "Vergani."
Processing 00000000.tx.668: 1992. 

Phrase: "1992."
Processing 00000000.tx.669: Alternative splicing of fibronectin pre-mRNA during aging. 

Phrase: "Alternative splicing of fibronectin pre-mRNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1622990:pre-mRNA splicing [Genetic Function]
   790   C0002345:Alternative Splicing [Genetic Function]
   783   C0086934:mRNA splicing [Genetic Function]
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]

Phrase: "during aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.670: Ann. 

Phrase: "Ann."
Processing 00000000.tx.671: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.672: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.673: 663: 477-478 36. 

Phrase: "663"

Phrase: ":"

Phrase: "477-478 36."
Processing 00000000.tx.674: Paresce, D.M., R.N. 

Phrase: "Paresce,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.675: Ghosh, and F.R. 

Phrase: "Ghosh,"

Phrase: "and"

Phrase: "F.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.676: Maxfield. 

Phrase: "Maxfield."
Processing 00000000.tx.677: 1996. 

Phrase: "1996."
Processing 00000000.tx.678: Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. 

Phrase: "Microglial cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0206116:Microglial cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "internalize"

Phrase: "aggregates of the Alzheimer's disease amyloid beta-protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205418:aggregates [Qualitative Concept]

Phrase: "via a scavenger receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0074129:scavenger receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017108:scavenger [Medical Device]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1003377:scavenger [Fish]
Processing 00000000.tx.679: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.680: 17: 553-565 37. 

Phrase: "17"

Phrase: ":"

Phrase: "553-565 37."
Processing 00000000.tx.681: Pike, C.J., D. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C.J.,"

Phrase: "D."
Processing 00000000.tx.682: Burdick, A.J. 

Phrase: "Burdick,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.683: Walencewicz, C.G. 

Phrase: "Walencewicz,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.684: Glabe, and C.W. 

Phrase: "Glabe,"

Phrase: "and"

Phrase: "C.W."
Processing 00000000.tx.685: Cotman. 

Phrase: "Cotman."
Processing 00000000.tx.686: 1993. 

Phrase: "1993."
Processing 00000000.tx.687: Neurodegeneration induced by amyloid peptides in vitro. 

Phrase: "Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "induced by amyloid peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205263:Induced [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.688: J. 

Phrase: "J."
Processing 00000000.tx.689: Neurosci 13: 1676-1687 [Abstract]. 

Phrase: "Neurosci 13"

Phrase: ":"

Phrase: "1676-1687"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.690: 38. 

Phrase: "38."
Processing 00000000.tx.691: Ruoslahti, E.. 

Phrase: "Ruoslahti,"

Phrase: "E.."
Processing 00000000.tx.692: 1996a. 

Phrase: "1996a."
Processing 00000000.tx.693: RGD and other recognition sequences for integrins. 

Phrase: "RGD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2699006:RGD [Intellectual Product]

Phrase: "and"

Phrase: "other recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "sequences for integrins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.694: Ann. 

Phrase: "Ann."
Processing 00000000.tx.695: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.696: Cell Dev. 

Phrase: "Cell Dev."
Processing 00000000.tx.697: 12: 697-715 39. 

Phrase: "12"

Phrase: ":"

Phrase: "697-715 39."
Processing 00000000.tx.698: Ruoslahti, E.. 

Phrase: "Ruoslahti,"

Phrase: "E.."
Processing 00000000.tx.699: 1996b. 

Phrase: "1996b."
Processing 00000000.tx.700: Brain extracellular matrix. 

Phrase: "Brain extracellular matrix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0015350:Extracellular Matrix [Tissue]
   827   C0521119:Extracellular [Cell Component]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.701: Glycobiology. 

Phrase: "Glycobiology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512223:Glycobiology [Occupation or Discipline]
Processing 00000000.tx.702: 6: 489-492 [Abstract]. 

Phrase: "6"

Phrase: ":"

Phrase: "489-492"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.703: 40. 

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.704: Sabo, S., M.P. 

Phrase: "Sabo,"

Phrase: "S."

Phrase: ","

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.705: Lambert, K. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.706: Kessey, W. 

Phrase: "Kessey,"

Phrase: "W."
Processing 00000000.tx.707: Wade, G. 

Phrase: "Wade"

Phrase: ","

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.708: Krafft, and W.L. 

Phrase: "Krafft,"

Phrase: "and"

Phrase: "W.L."
Processing 00000000.tx.709: Klein. 

Phrase: "Klein."
Processing 00000000.tx.710: 1995. 

Phrase: "1995."
Processing 00000000.tx.711: Interaction of beta-amyloid peptides with integrins in a human nerve cell line. 

Phrase: "Interaction of beta-amyloid peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "in a human nerve cell line."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0682523:Human Cell Line [Cell]
   895   C0814990:neural cell line [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   708   C0427861:human cell [Laboratory or Test Result]
Processing 00000000.tx.712: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.713: Lett. 

Phrase: "Lett."
Processing 00000000.tx.714: 184: 25-28 41. 

Phrase: "184"

Phrase: ":"

Phrase: "25-28 41."
Processing 00000000.tx.715: Sargent Jones, L. 

Phrase: "Sargent Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.716: 1996. 

Phrase: "1996."
Processing 00000000.tx.717: Integrins: possible functions in the adult CNS. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ":"

Phrase: "possible functions in the adult CNS."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   783   C0683212:cns functions [Organ or Tissue Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.718: Trends Neurosci 19: 68-72 42. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 19"

Phrase: ":"

Phrase: "68-72 42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450387:68 [Intellectual Product]
Processing 00000000.tx.719: Schreiner, C.L., J.S. 

Phrase: "Schreiner,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "J.S."
Processing 00000000.tx.720: Bauer, Y.N. 

Phrase: "Bauer,"

Phrase: "Y.N."
Processing 00000000.tx.721: Danilov, S. 

Phrase: "Danilov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.722: Hussein, M.M. 

Phrase: "Hussein,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.723: Sczekan, and R.L. 

Phrase: "Sczekan,"

Phrase: "and"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.724: Juliano. 

Phrase: "Juliano."
Processing 00000000.tx.725: 1989. 

Phrase: "1989."
Processing 00000000.tx.726: Isolation and characterization of Chinese hamster cell variants deficient in the expression of fibronectin receptor. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "characterization of Chinese hamster cell variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "deficient in the expression of fibronectin receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011155:Deficient [Functional Concept]
   748   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.727: J. 

Phrase: "J."
Processing 00000000.tx.728: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.729: 109: 3157-3167 [Abstract]. 

Phrase: "109"

Phrase: ":"

Phrase: "3157-3167"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.730: 43. 

Phrase: "43."
Processing 00000000.tx.731: Selkoe, D.J.. 

Phrase: "Selkoe,"

Phrase: "D.J.."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.732: 1994. 

Phrase: "1994."
Processing 00000000.tx.733: Cell biology of the amyloid -protein precursor and the mechanism of Alzheimer's disease. 

Phrase: "Cell biology of the amyloid -protein precursor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   748   C0005532:Biology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "the mechanism of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.734: Annu. 

Phrase: "Annu."
Processing 00000000.tx.735: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.736: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.737: Biol 10: 373-403 . 44. 

Phrase: "Biol 10"

Phrase: ":"

Phrase: "373-403 . 44."
Processing 00000000.tx.738: Seubert, P., C. 

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "C."
Processing 00000000.tx.739: Vigo-Pelfrey, F. 

Phrase: "Vigo-Pelfrey,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.740: Esch, M. 

Phrase: "Esch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.741: Lee, H. 

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.742: Dovey, D. 

Phrase: "Dovey,"

Phrase: "D."
Processing 00000000.tx.743: Davis, S. 

Phrase: "Davis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.744: Sinha, M. 

Phrase: "Sinha,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.745: Schlossmacher, J. 

Phrase: "Schlossmacher,"

Phrase: "J."
Processing 00000000.tx.746: Whaley, C. 

Phrase: "Whaley,"

Phrase: "C."
Processing 00000000.tx.747: Swindlehurst, et al . 1992. 

Phrase: "Swindlehurst,"

Phrase: "et al . 1992."
Processing 00000000.tx.748: Isolation and quantification of soluble Alzheimer's -peptide from biological fluids. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "quantification of soluble Alzheimer's -peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "from biological fluids."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0005889:Fluids [Body Substance]
   861   C0302908:fluids [Substance]
   861   C1521806:Fluids [Tissue]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]
Processing 00000000.tx.749: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.750: 359: 325-327 45. 

Phrase: "359"

Phrase: ":"

Phrase: "325-327 45."
Processing 00000000.tx.751: Suzuki, N., T.T. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "T.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.752: Cheung, X.D. 

Phrase: "Cheung,"

Phrase: "X.D."
Processing 00000000.tx.753: Cai, A. 

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.754: Odaka, L.J. 

Phrase: "Odaka,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.755: Otvos, C. 

Phrase: "Otvos,"

Phrase: "C."
Processing 00000000.tx.756: Eckman, T.E. 

Phrase: "Eckman,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.757: Golde, and S.G. 

Phrase: "Golde,"

Phrase: "and S.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.758: Younkin. 

Phrase: "Younkin."
Processing 00000000.tx.759: 1994. 

Phrase: "1994."
Processing 00000000.tx.760: An increased percentage of long amyloid protein secreted by familial amyloid protein precursor (APP717) mutants. 

Phrase: "An increased percentage of long amyloid protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "secreted by familial amyloid protein precursor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0015576:familial [Family Group]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0241888:Familial [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1327616:Secreted [Cell Function]
   753   C1709634:Precursor [Idea or Concept]
   748   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APP717"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0299605:APP717 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.761: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.762: 264: 1336-1340 46. 

Phrase: "264"

Phrase: ":"

Phrase: "1336-1340 46."
Processing 00000000.tx.763: Tada, H., O. 

Phrase: "Tada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.764: Shiho, K.-I. 

Phrase: "Shiho,"

Phrase: "K.-I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.765: Kuroshima, M. 

Phrase: "Kuroshima,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.766: Koyama, and K. 

Phrase: "Koyama,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.767: Tsukamoto. 

Phrase: "Tsukamoto."
Processing 00000000.tx.768: 1986. 

Phrase: "1986."
Processing 00000000.tx.769: An improved colorimetric assay for interleukin 2. 

Phrase: "An improved colorimetric assay for interleukin 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0493611:ASSAY, INTERLEUKIN [Medical Device]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.770: J. 

Phrase: "J."
Processing 00000000.tx.771: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.772: Methods 93: 157-165 47. 

Phrase: "Methods 93"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "157-165 47."
Processing 00000000.tx.773: Tawil, N.J., P. 

Phrase: "Tawil,"

Phrase: "N.J.,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.774: Wilson, and S. 

Phrase: "Wilson,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.775: Carbonetto. 

Phrase: "Carbonetto."
Processing 00000000.tx.776: 1994. 

Phrase: "1994."
Processing 00000000.tx.777: Expression and distribution of functional integrins in rat CNS glia. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "distribution of functional integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in rat CNS glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027836:Glia [Cell]
   827   C1087003:Glia [Plant]
Processing 00000000.tx.778: J. 

Phrase: "J."
Processing 00000000.tx.779: Neurosci 39: 436-447 . 48. 

Phrase: "Neurosci 39"

Phrase: ":"

Phrase: "436-447 . 48."
Processing 00000000.tx.780: Wary, K.K., F. 

Phrase: "Wary, K.K.,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.781: Mainiero, S.J. 

Phrase: "Mainiero,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.782: Isakoff, E.E. 

Phrase: "Isakoff,"

Phrase: "E.E."
Processing 00000000.tx.783: Marcantonio, and F.G. 

Phrase: "Marcantonio,"

Phrase: "and"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.784: Giancotti. 

Phrase: "Giancotti."
Processing 00000000.tx.785: 1996. 

Phrase: "1996."
Processing 00000000.tx.786: The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. 

Phrase: "The adaptor protein Shc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705297:SHC [Gene or Genome]
   734   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "couples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:Couples [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "a class of integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "to the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of cell cycle progression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1516334:Cell Cycle Progression [Cell Function]
   827   C0242656:progression [Pathologic Function]
   827   C0449258:Progression [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]
Processing 00000000.tx.787: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.788: 87: 733-743 49. 

Phrase: "87"

Phrase: ":"

Phrase: "733-743 49."
Processing 00000000.tx.789: Watari, M., S. 

Phrase: "Watari,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.790: Funato, and C. 

Phrase: "Funato,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.791: Sasakawa. 

Phrase: "Sasakawa."
Processing 00000000.tx.792: 1996. 

Phrase: "1996."
Processing 00000000.tx.793: Interaction of Ipa proteins of Shigella Glexneri with alpha 5beta 1integrin promotes entry of the bacteria into mammalian cells. 

Phrase: "Interaction of Ipa proteins of Shigella Glexneri"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "with alpha 5beta 1integrin"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "entry of the bacteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705654:Entry [Intellectual Product]

Phrase: "into mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.794: J. 

Phrase: "J."
Processing 00000000.tx.795: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.796: Med 183: 991-999 [Abstract]. 

Phrase: "Med 183"

Phrase: ":"

Phrase: "991-999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.797: 50. 

Phrase: "50."
Processing 00000000.tx.798: Wayner, E.A., W.G. 

Phrase: "Wayner,"

Phrase: "E.A.,"

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.799: Carter, R.S. 

Phrase: "Carter,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.800: Piotrowicz, and T.J. 

Phrase: "Piotrowicz,"

Phrase: "and"

Phrase: "T.J."
Processing 00000000.tx.801: Kunicki. 

Phrase: "Kunicki."
Processing 00000000.tx.802: 1988. 

Phrase: "1988."
Processing 00000000.tx.803: The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoprotein Ic-IIa. 

Phrase: "The function of multiple extracellular matrix receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0920644:function receptors [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cell adhesion to extracellular matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0887869:cell-matrix adhesion [Cell Component]
   806   C0007577:Cell Adhesion [Cell Function]
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "preparation of monoclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C1298636:Monoclonal antibody preparation [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "to the fibronectin receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0081938:Fibronectin receptor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1138422:Fibronectin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that specifically"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cell adhesion to fibronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "react with platelet glycoprotein Ic-IIa."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C1138422:Platelet Glycoprotein Ic-IIa [Amino Acid, Peptide, or Protein,Receptor]
   833   C0298340:Platelet Glycoprotein Ic [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0086816:Platelet glycoprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1416496:GLYCOPROTEIN IIa [Gene or Genome]
   753   C0005821:Platelet [Cell]
   753   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
Processing 00000000.tx.804: J. 

Phrase: "J."
Processing 00000000.tx.805: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.806: 107: 1881-1891 [Abstract]. 

Phrase: "107"

Phrase: ":"

Phrase: "1881-1891"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.807: 51. 

Phrase: "51."
Processing 00000000.tx.808: Yamazaki, T., E.J. 

Phrase: "Yamazaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "E.J."
Processing 00000000.tx.809: Koo, and D.J. 

Phrase: "Koo,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.810: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.811: 1997. 

Phrase: "1997."
Processing 00000000.tx.812: Cell surface amyloid -protein precursor colocalizes with 1 integrins at substrate contact sites in neural cells. 

Phrase: "Cell surface amyloid -protein precursor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "colocalizes with 1 integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "at substrate contact sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C2752541:contact site [Cell Component]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "in neural cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0027882:Neural cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.813: J. 

Phrase: "J."
Processing 00000000.tx.814: Neurosci 17: 1004-1010 [Abstract/Free FullText]. 

Phrase: "Neurosci 17"

Phrase: ":"

Phrase: "1004-1010"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.815: 52. 

Phrase: "52."
Processing 00000000.tx.816: Yan, S., X. 

Phrase: "Yan,"

Phrase: "S."

Phrase: ","

Phrase: "X."
Processing 00000000.tx.817: Chen, J. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.818: Fu, M. 

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.819: Chen, Z. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."
Processing 00000000.tx.820: Huaijie, A. 

Phrase: "Huaijie,"

Phrase: "A."
Processing 00000000.tx.821: Roher, T. 

Phrase: "Roher,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.822: Slattery, L. 

Phrase: "Slattery,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.823: Zhao, M. 

Phrase: "Zhao,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.824: Nagashima, J. 

Phrase: "Nagashima,"

Phrase: "J."
Processing 00000000.tx.825: Morser, et al . 1996. 

Phrase: "Morser,"

Phrase: "et al . 1996."
Processing 00000000.tx.826: RAGE and amyloid- peptide neurotoxicity in Alzheimer's disease. 

Phrase: "RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034634:Rage [Mental Process]
  1000   C3539760:RAGE [Gene or Genome]

Phrase: "and"

Phrase: "amyloid- peptide neurotoxicity in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.827: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.828: 382: 685-691 53. 

Phrase: "382"

Phrase: ":"

Phrase: "685-691 53."
Processing 00000000.tx.829: Yang, A.J., M. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.830: Knauer, D.A. 

Phrase: "Knauer,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.831: Burdick, and C. 

Phrase: "Burdick,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.832: Glabe. 

Phrase: "Glabe."
Processing 00000000.tx.833: 1995. 

Phrase: "1995."
Processing 00000000.tx.834: Intracellular A1-42 aggregates stimulate the accumulation of stable, insoluble, amyloidogenic fragments of the amyloid precursor protein in transfected cells. 

Phrase: "Intracellular A1-42 aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "stimulate"

Phrase: "the accumulation of stable, insoluble, amyloidogenic fragments of the amyloid precursor protein"

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.835: J. 

Phrase: "J."
Processing 00000000.tx.836: Biol. 

Phrase: "Biol."
Processing 00000000.tx.837: Chem 270: 14786-14792 [Abstract/Free FullText]. 

Phrase: "Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "14786-14792"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.838: 54. 

Phrase: "54."
Processing 00000000.tx.839: Yatohgo, T., M. 

Phrase: "Yatohgo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.840: Izumi, H. 

Phrase: "Izumi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.841: Kashiwagi, and M. 

Phrase: "Kashiwagi,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.842: Hayashi. 

Phrase: "Hayashi."
Processing 00000000.tx.843: 1988. 

Phrase: "1988."
Processing 00000000.tx.844: Novel purification of vitronectin from human plasma by heparin affinity chromatography. 

Phrase: "Novel purification of vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "from human plasma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0544357:Human plasma [Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0086418:Human [Human]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "by heparin affinity chromatography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0008551:Chromatography, Affinity [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.845: Cell Struct. 

Phrase: "Cell Struct."
Processing 00000000.tx.846: Funct. 

Phrase: "Funct."
Processing 00000000.tx.847: 13: 281-292 55. 

Phrase: "13"

Phrase: ":"

Phrase: "281-292 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450382:55 [Intellectual Product]
Processing 00000000.tx.848: Zhang, Z., K. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.849: Vuori, J.C. 

Phrase: "Vuori,"

Phrase: "J.C."
Processing 00000000.tx.850: Reed, and E. 

Phrase: "Reed,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.851: Ruoslahti. 

Phrase: "Ruoslahti."
Processing 00000000.tx.852: 1995. 

Phrase: "1995."
Processing 00000000.tx.853: The 51 integrin supports survival of cells on fibronectin and up-regulates BCL-2 expression. 

Phrase: "The 51 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "survival of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C0007620:Cell Survival [Cell Function]
   790   C0038952:Survival [Activity]
   790   C0220921:survival [Functional Concept]

Phrase: "on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "BCL-2 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.854: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.855: Natl. 

Phrase: "Natl."
Processing 00000000.tx.856: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.857: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.858: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.859: 92: 6161-6165 [Abstract/Free FullText]. 

Phrase: "92"

Phrase: ":"

Phrase: "6161-6165"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.860: 56. 

Phrase: "56."
Processing 00000000.tx.861: Zhang, Z., A.O. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "A.O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029408:a o [Disease or Syndrome]
Processing 00000000.tx.862: Morla, K. 

Phrase: "Morla,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.863: Vuori, J.S. 

Phrase: "Vuori,"

Phrase: "J.S."
Processing 00000000.tx.864: Bauer, R.L. 

Phrase: "Bauer,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.865: Juliano, and E. 

Phrase: "Juliano,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.866: Ruoslahti. 

Phrase: "Ruoslahti."
Processing 00000000.tx.867: 1993. 

Phrase: "1993."
Processing 00000000.tx.868: The av1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. 

Phrase: "The av1 integrin functions as a fibronectin receptor"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0920644:function receptor [Molecular Function]
   744   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "fibronectin matrix assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "cell migration on fibronectin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1622501:Migration, Cell [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.869: J. 

Phrase: "J."
Processing 00000000.tx.870: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.871: Biol. 

Phrase: "Biol."
Processing 00000000.tx.872: 122: 235-247 [Abstract]. 

Phrase: "122"

Phrase: ":"

Phrase: "235-247"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.873: Copyright  1998 by The Rockefeller University Press. 

Phrase: "Copyright  1998 by The Rockefeller University Press."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0009993:Copyright [Intellectual Product]
   748   C0041740:University [Manufactured Object,Organization]
   748   C1552856:copyright [Idea or Concept]
Processing 00000000.tx.874: 0021-9525/98/05/1019/12 $2.00

Phrase: "0021-9525/98/05/1019/12 $2.00"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0450318:1019 [Intellectual Product]

